- RADCLIFFE C, Kotton CN
En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era.
Ann Intern Med. 2024 Apr 9. doi: 10.7326/M24-0256.
PubMed
Antiviral Res - TOLKSDORF B, Heinze J, Niemeyer D, Rohrs V, et al
Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses.
Antiviral Res. 2024 Apr 8:105879. doi: 10.1016/j.antiviral.2024.105879.
PubMed Abstract available
Clin Infect Dis - MCAULEY JB
COVID at the Whiteriver Indian Hospital.
Clin Infect Dis. 2024;78:815-817.
PubMed - ZAWADZKA S
Family Ties and COVID Lies.
Clin Infect Dis. 2024;78:813-814.
PubMed - TIPPETT A, Ess G, Hussaini L, Reese O, et al
Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
PubMed Abstract available - VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
PubMed Abstract available - SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
PubMed Abstract available - PETROS BA, Milliren CE, Sabeti PC, Ozonoff A, et al
Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing.
Clin Infect Dis. 2024 Apr 11:ciae140. doi: 10.1093.
PubMed Abstract available - RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
PubMed Abstract available
Int J Infect Dis - MARKUSSEN DL, Kommedal O, Knoop ST, Ebbesen MH, et al
Microbial aetiology of community-acquired pneumonia in hospitalized adults: a prospective study utilising comprehensive molecular testing.
Int J Infect Dis. 2024 Apr 4:107019. doi: 10.1016/j.ijid.2024.107019.
PubMed Abstract available - TAMURA K, Shimbashi R, Kasamatsu A, Chang B, et al
Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan.
Int J Infect Dis. 2024 Apr 5:107024. doi: 10.1016/j.ijid.2024.107024.
PubMed Abstract available - FAVRESSE J, Gillot C, Cabo J, David C, et al
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1 and JN.1 six months after the BNT162b2 bivalent booster.
Int J Infect Dis. 2024 Apr 5:107028. doi: 10.1016/j.ijid.2024.107028.
PubMed Abstract available - YU J, Zhang K, Chen T, Lin R, et al
Temporal patterns of organ dysfunction in COVID-19 patients hospitalized in the intensive care unit: A group-based multitrajectory modelling analysis.
Int J Infect Dis. 2024 Apr 9:107045. doi: 10.1016/j.ijid.2024.107045.
PubMed Abstract available
J Infect - PINANA M, Gonzalez-Sanchez A, Andres C, Vila J, et al
Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
J Infect. 2024 Apr 6:106153. doi: 10.1016/j.jinf.2024.106153.
PubMed Abstract available
J Med Virol - ARUNAN B, Talukdar D, Swain S, Varadarajan A, et al
Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID-19 associated mucormycosis patients from India.
J Med Virol. 2024;96:e29601.
PubMed Abstract available - LI Y, Yu J, Wang Y, Yi J, et al
Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study.
J Med Virol. 2024;96:e29602.
PubMed Abstract available - PARK D, Kim SM, Jang H, Kim K, et al
Differential beta-coronavirus infection dynamics in human bronchial epithelial organoids.
J Med Virol. 2024;96:e29600.
PubMed Abstract available - SVIERCZ F, Jarmoluk P, Godoy Coto J, Cevallos C, et al
The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts.
J Med Virol. 2024;96:e29597.
PubMed Abstract available - RAI P, Marano JM, Kang L, Coutermarsh-Ott S, et al
Obesity fosters severe disease outcomes in a mouse model of coronavirus infection associated with transcriptomic abnormalities.
J Med Virol. 2024;96:e29587.
PubMed Abstract available - KURYLOWICZ A, Babicki M, Wasowski M, Jankowski P, et al
Triglicerydes/high-density lipoprotein ratio as a risk factor of post-Covid-19 sinus tachycardia: A retrospective study.
J Med Virol. 2024;96:e29586.
PubMed Abstract available - YE G, Tang Y, Yang Q, Zhang C, et al
A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity.
J Med Virol. 2024;96:e29492.
PubMed
J Travel Med - CHEMAITELLY H, Coyle P, Kacem MAB, Ayoub HH, et al
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant.
J Travel Med. 2024 Apr 9:taae053. doi: 10.1093.
PubMed Abstract available
J Virol - BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
PubMed Abstract available - ZHOU J, Sun P, Wang Y, Qiu R, et al
Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease.
J Virol. 2024 Apr 9:e0025324. doi: 10.1128/jvi.00253.
PubMed Abstract available - YANG R, Han P, Han P, Li D, et al
Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
PubMed Abstract available
JAMA - HARRIS E
COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
PubMed - DAWOOD FS, Payne AB, McMorrow ML
Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
PubMed
Lancet
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
PubMed Abstract available- GU X, Huang L, Zhang H, Cao B, et al
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan – Authors’ reply.
Lancet. 2024;403:1336-1337.
PubMed - SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
Lancet. 2024;403:1336.
PubMed - HASHIM Z, Nath A, Tripathy NK
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1337-1338.
PubMed - MCEVOY N, Lowry J, O’Dowd A, Curley GF, et al
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1337.
PubMed - HSU NC, Tokuda Y
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1338.
PubMed - NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1338-1339.
PubMed - BHUSAL S, Adhikari S
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
Lancet. 2024;403:1339.
PubMed - PETO L, Basnyat B, Horby P
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors’ reply.
Lancet. 2024;403:1339-1340.
PubMed - ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
Anticipating a MERS-like coronavirus as a potential pandemic threat.
Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
PubMed
Lancet Infect Dis - PELUSO MJ, Swank ZN, Goldberg SA, Lu S, et al
Plasma-based antigen persistence in the post-acute phase of COVID-19.
Lancet Infect Dis. 2024 Apr 8:S1473-3099(24)00211.
PubMed
MMWR Morb Mortal Wkly Rep - DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
COVID-19 Vaccination Coverage – World Health Organization African Region, 2021-2023.
MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
PubMed Abstract available - LIKO J, Cieslak PR
Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine – Oregon, June 2021-December 2022.
MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
PubMed Abstract available
N Engl J Med - HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
N Engl J Med. 2024;390:1186-1195.
PubMed Abstract available - GANDHI RT, Hirsch M
Treating Acute Covid-19 – Final Chapters Still Unwritten.
N Engl J Med. 2024;390:1234-1236.
PubMed
Zhonghua Jie He He Hu Xi Za Zhi - SUN ZZ, Sun GF, Zhuang R, Zhu LQ, et al
[Best evidence summary for awake prone positioning in treating hypoxemic due to COVID-19 infection].
Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:313-318.
PubMed Abstract available
Tag: abstract
#Influenza and #COVID19 Research References (by AMEDEO, July 30 ’22)
1. DE FOO C, Haldane V, Jung AS, Grepin KA, et al.
Isolation facilities for covid-19: towards a person centred approach.
BMJ. 2022;378:e069558.
PubMed: http://www.amedeo.com/p2.php?id=35882391&s=flu&pm=2
Share: http://m.amedeo.com/35882391
2. WISE J.
Covid-19: Infection raises risk of diabetes and heart disease diagnoses in
following weeks, study finds.
BMJ. 2022;378:o1838.
PubMed: http://www.amedeo.com/p2.php?id=35868645&s=flu&pm=2
Share: http://m.amedeo.com/35868645
3. BEHERA J, Ison J, Voor MJ, Tyagi SC, et al.
Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
Biochem Biophys Res Commun. 2022;620:180-187.
PubMed: http://www.amedeo.com/p2.php?id=35803174&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35803174
4. MISHRA PM, Anjum F, Uversky VN, Nandi CK, et al.
SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human
ACE2 receptors.
Biochem Biophys Res Commun. 2022;620:8-14.
PubMed: http://www.amedeo.com/p2.php?id=35772213&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35772213
5. SEBINA I, Rashid RB, Sikder MAA, Rahman MM, et al.
IFN-lambda Diminishes the Severity of Viral Bronchiolitis in Neonatal Mice by
Limiting NADPH Oxidase-Induced PAD4-Independent NETosis.
J Immunol. 2022;208:2806-2816.
PubMed: http://www.amedeo.com/p2.php?id=35675958&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35675958
6. CHEN Y, Ye Z, Zhang Y, Xie W, et al.
A Deep Learning Model for Accurate Diagnosis of Infection Using Antibody
Repertoires.
J Immunol. 2022;208:2675-2685.
PubMed: http://www.amedeo.com/p2.php?id=35606050&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35606050
7. BRITTO C, Mohorianu I, Yeung T, Cheung E, et al.
Host respiratory transcriptome signature associated with poor outcome in children
with influenza-Staphylococcus aureus pneumonia.
J Infect Dis. 2022 Jul 28. pii: 6650994. doi: 10.1093.
PubMed: http://www.amedeo.com/p2.php?id=35899844&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35899844
8. BI W, Chen G, Dang B.
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and
Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
PubMed: http://www.amedeo.com/p2.php?id=35735997&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35735997
9. CHAN CE, Ng CG, Lim AP, Seah SL, et al.
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells
Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
PubMed: http://www.amedeo.com/p2.php?id=35727030&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35727030
10. LIN J, Law R, Korosec CS, Zhou C, et al.
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing
Responses for 1 Year Reveals Persistence of Multicytokine Proliferative
Responses, with Greater Immunity Associated with Disease Severity.
J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
PubMed: http://www.amedeo.com/p2.php?id=35699447&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35699447
11. SUN C, Yuan RY, Xie C, Sun JF, et al.
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by
S1 Nanoparticle Vaccines.
J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
PubMed: http://www.amedeo.com/p2.php?id=35699445&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35699445
12. BEACH SS, Hull MA, Ytreberg FM, Patel JS, et al.
Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory
Syncytial Virus Fusion Glycoprotein.
J Virol. 2022;96:e0035322.
PubMed: http://www.amedeo.com/p2.php?id=35678603&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35678603
13. LAVIE M, Dubuisson J, Belouzard S.
SARS-CoV-2 Spike Furin Cleavage Site and S2′ Basic Residues Modulate the Entry
Process in a Host Cell-Dependent Manner.
J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
PubMed: http://www.amedeo.com/p2.php?id=35678602&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35678602
14. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al.
A So-Far Overlooked Secondary Conformation State in the Binding Mode of
SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for
Estimating Infectivity Efficacy of the Underlying Virus Variant.
J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
PubMed: http://www.amedeo.com/p2.php?id=35674432&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35674432
15. CHEN X, Li J, Yang L, Zhou Y, et al.
Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification
and Differentiation of Infected from Vaccinated Hosts.
J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
PubMed: http://www.amedeo.com/p2.php?id=35658531&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35658531
16. ZENG G.
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
JAMA. 2022;328:395.
PubMed: http://www.amedeo.com/p2.php?id=35881131&s=flu&pm=2
Share: http://m.amedeo.com/35881131
17. ULLOA AC, Buchan SA, Brown KA.
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
JAMA. 2022;328:395-396.
PubMed: http://www.amedeo.com/p2.php?id=35881128&s=flu&pm=2
Share: http://m.amedeo.com/35881128
18. SLOMSKI A.
Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
JAMA. 2022;328:322.
PubMed: http://www.amedeo.com/p2.php?id=35881125&s=flu&pm=2
Share: http://m.amedeo.com/35881125
19. KUEHN BM.
Persistent Disparities in COVID-19 Antiviral Dispensing.
JAMA. 2022;328:323.
PubMed: http://www.amedeo.com/p2.php?id=35881114&s=flu&pm=2
Share: http://m.amedeo.com/35881114
20. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al.
Changes in the Relationship Between Income and Life Expectancy Before and During
the COVID-19 Pandemic, California, 2015-2021.
JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.
PubMed: http://www.amedeo.com/p2.php?id=35797033&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35797033
21. GOGA A, Bekker LG, Garrett N, Reddy T, et al.
Breakthrough SARS-CoV-2 infections during periods of delta and omicron
predominance, South Africa.
Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
PubMed: http://www.amedeo.com/p2.php?id=35809579&s=flu&pm=2
Share: http://m.amedeo.com/35809579
22. LINK-GELLES R, Levy ME, Gaglani M, Irving SA, et al.
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent
Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages
Predominated – VISION Network, 10 States, December 2021-June 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:931-939.
PubMed: http://www.amedeo.com/p2.php?id=35862287&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35862287
23. KONE A, Horter L, Thomas I, Byrkit R, et al.
Symptoms of Mental Health Conditions and Suicidal Ideation Among State, Tribal,
Local, and Territorial Public Health Workers – United States, March 14-25, 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:925-930.
PubMed: http://www.amedeo.com/p2.php?id=35862276&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35862276
24. HARE BORK R, Robins M, Schaffer K, Leider JP, et al.
Workplace Perceptions and Experiences Related to COVID-19 Response Efforts Among
Public Health Workers – Public Health Workforce Interests and Needs Survey,
United States, September 2021-January 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:920-924.
PubMed: http://www.amedeo.com/p2.php?id=35862270&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35862270
25. VU MN, Lokugamage KG, Plante JA, Scharton D, et al.
QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2
infection and pathogenesis.
Proc Natl Acad Sci U S A. 2022;119:e2205690119.
PubMed: http://www.amedeo.com/p2.php?id=35881779&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35881779
26. XU Z, Choi JH, Dai DL, Luo J, et al.
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA
translation.
Proc Natl Acad Sci U S A. 2022;119:e2204539119.
PubMed: http://www.amedeo.com/p2.php?id=35878012&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35878012
27. GUO K, Barrett BS, Morrison JH, Mickens KL, et al.
Interferon resistance of emerging SARS-CoV-2 variants.
Proc Natl Acad Sci U S A. 2022;119:e2203760119.
PubMed: http://www.amedeo.com/p2.php?id=35867811&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35867811
28. IOANNIDIS JPA, Bendavid E, Salholz-Hillel M, Boyack KW, et al.
Massive covidization of research citations and the citation elite.
Proc Natl Acad Sci U S A. 2022;119:e2204074119.
PubMed: http://www.amedeo.com/p2.php?id=35867747&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35867747
29. HAN M, Gao S, Hu W, Zhou Q, et al.
Inhibitory effects of cedar pine needle extract on H9N2 avian influenza virus in
vitro and in vivo.
Virology. 2022;574:25-36.
PubMed: http://www.amedeo.com/p2.php?id=35878455&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35878455
Share this:
#Influenza and #COVID19 Research References (by AMEDEO, July 15 ’22)
1. KIM EH, Lee BW, Ryu B, Cho HM, et al.
Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in
hACE2 mice.
Antiviral Res. 2022;204:105371.
PubMed: http://www.amedeo.com/p2.php?id=35777669&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35777669
2. SEEPHETDEE C, Bhukhai K, Buasri N, Leelukkanaveera P, et al.
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad
neutralization of SARS-CoV-2 variants by mouse sera.
Antiviral Res. 2022 Jun 27:105370. doi: 10.1016/j.antiviral.2022.105370.
PubMed: http://www.amedeo.com/p2.php?id=35772601&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35772601
3. KARIM M, Saul S, Ghita L, Sahoo MK, et al.
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular
targets for antiviral strategies.
Antiviral Res. 2022 Jun 20:105367. doi: 10.1016/j.antiviral.2022.105367.
PubMed: http://www.amedeo.com/p2.php?id=35738348&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35738348
4. ZHOU M, Liu Y, Cao J, Dong S, et al.
Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in
golden Syrian hamsters.
Antiviral Res. 2022 Jun 19:105365. doi: 10.1016/j.antiviral.2022.105365.
PubMed: http://www.amedeo.com/p2.php?id=35732228&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35732228
5. CIVRA A, Costantino M, Cavalli R, Adami M, et al.
27-Hydroxycholesterol inhibits rhinovirus replication in vitro and on human nasal
and bronchial histocultures without selecting viral resistant variants.
Antiviral Res. 2022;204:105368.
PubMed: http://www.amedeo.com/p2.php?id=35732227&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35732227
6. HERNANDEZ S, Feracci M, De Jesus CT, El Kazzi P, et al.
Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases
by fluorescence polarization assay.
Antiviral Res. 2022 Jun 15:105364. doi: 10.1016/j.antiviral.2022.105364.
PubMed: http://www.amedeo.com/p2.php?id=35716929&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35716929
7. MELO-FILHO CC, Bobrowski T, Martin HJ, Sessions Z, et al.
Conserved coronavirus proteins as targets of broad-spectrum antivirals.
Antiviral Res. 2022 Jun 9:105360. doi: 10.1016/j.antiviral.2022.105360.
PubMed: http://www.amedeo.com/p2.php?id=35691424&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35691424
8. MERCORELLI B, Desantis J, Celegato M, Bazzacco A, et al.
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by
virtual screenings and hit optimization.
Antiviral Res. 2022;204:105350.
PubMed: http://www.amedeo.com/p2.php?id=35688349&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35688349
9. MAHASE E.
Covid-19: Ethnic minority staff felt “vulnerable” during pandemic, says senior
leader.
BMJ. 2022;378:o1715.
PubMed: http://www.amedeo.com/p2.php?id=35817461&s=flu&pm=2
Share: http://m.amedeo.com/35817461
10. WILKINSON E.
Covid-19: Hospitals and GP clinics return to universal mask wearing as rates
rise.
BMJ. 2022;378:o1712.
PubMed: http://www.amedeo.com/p2.php?id=35817443&s=flu&pm=2
Share: http://m.amedeo.com/35817443
11. BOYLE A.
Workforce: the persistent victim of the covid-19 pandemic.
BMJ. 2022;378:o1702.
PubMed: http://www.amedeo.com/p2.php?id=35817439&s=flu&pm=2
Share: http://m.amedeo.com/35817439
12. TANNE JH.
Covid-19: FDA authorises pharmacists to prescribe Paxlovid.
BMJ. 2022;378:o1695.
PubMed: http://www.amedeo.com/p2.php?id=35803606&s=flu&pm=2
Share: http://m.amedeo.com/35803606
13. KAMINSKAITE V, Bluemel AH.
Impact of the covid-19 pandemic on medical school applicants.
BMJ. 2022;378:o1398.
PubMed: http://www.amedeo.com/p2.php?id=35803605&s=flu&pm=2
Share: http://m.amedeo.com/35803605
14. DYER O.
Covid vaccines: Canada to dispose of 13.6 million AstraZeneca doses owing to lack
of demand.
BMJ. 2022;378:o1700.
PubMed: http://www.amedeo.com/p2.php?id=35803604&s=flu&pm=2
Share: http://m.amedeo.com/35803604
15. TAYLOR L.
Covid-19: WHO urges countries to plug immunity gaps as global infections rise.
BMJ. 2022;378:o1685.
PubMed: http://www.amedeo.com/p2.php?id=35798379&s=flu&pm=2
Share: http://m.amedeo.com/35798379
16. STRAIN D.
Removing special covid leave will only undervalue staff and threaten patient
safety.
BMJ. 2022;378:o1684.
PubMed: http://www.amedeo.com/p2.php?id=35798378&s=flu&pm=2
Share: http://m.amedeo.com/35798378
17. TUEKPRAKHON A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, et al.
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Cell. 2022;185:2422-2433.
PubMed: http://www.amedeo.com/p2.php?id=35772405&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35772405
18. KAO J, Frankland PW.
COVID fog demystified.
Cell. 2022;185:2391-2393.
PubMed: http://www.amedeo.com/p2.php?id=35768007&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35768007
19. FERNANDEZ-CASTANEDA A, Lu P, Geraghty AC, Song E, et al.
Mild respiratory COVID can cause multi-lineage neural cell and myelin
dysregulation.
Cell. 2022;185:2452-2468.
PubMed: http://www.amedeo.com/p2.php?id=35768006&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35768006
20. ZHANG Z, Mateus J, Coelho CH, Dan JM, et al.
Humoral and cellular immune memory to four COVID-19 vaccines.
Cell. 2022;185:2434-2451.
PubMed: http://www.amedeo.com/p2.php?id=35764089&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35764089
21. AGUDELO M, Muecksch F, Schaefer-Babajew D, Cho A, et al.
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited
cross-protection to other variants.
J Exp Med. 2022;219.
PubMed: http://www.amedeo.com/p2.php?id=35796685&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35796685
22. SHARTOUNY JR, Lowen AC.
Message in a bottle: mRNA vaccination for influenza.
J Gen Virol. 2022;103.
PubMed: http://www.amedeo.com/p2.php?id=35830333&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35830333
23. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al.
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe
COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of
January-April, 2022.
Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
PubMed: http://www.amedeo.com/p2.php?id=35780801&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35780801
24. LADHANI SN.
COVID-19 vaccination for children aged 5-11 years.
Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
PubMed: http://www.amedeo.com/p2.php?id=35780800&s=flu&pm=2
Share: http://m.amedeo.com/35780800
25. SINGSON JRC, Kirley PD, Pham H, Rothrock G, et al.
Factors Associated with Severe Outcomes Among Immunocompromised Adults
Hospitalized for COVID-19 – COVID-NET, 10 States, March 2020-February 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:878-884.
PubMed: http://www.amedeo.com/p2.php?id=35797216&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35797216
26. WYPLOSZ B, Fernandes J, Sultan A, Roche N, et al.
Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year
French national observational study.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00841.
PubMed: http://www.amedeo.com/p2.php?id=35811205&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35811205
27. ZHANG Y, Wang Y, Jia C, Li G, et al.
Immunogenicity and safety of an egg culture-based quadrivalent inactivated
non-adjuvanted subunit influenza vaccine in subjects >/=3 years: A randomized,
multicenter, double-blind, active-controlled phase III, non-inferiority trial.
Vaccine. 2022 Jul 7. pii: S0264-410X(22)00846.
PubMed: http://www.amedeo.com/p2.php?id=35810063&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35810063
28. CHADWICK C, Friede M, Moen A, Nannei C, et al.
Technology transfer programme for influenza vaccines – Lessons from the past to
inform the future.
Vaccine. 2022 Jul 6. pii: S0264-410X(22)00826.
PubMed: http://www.amedeo.com/p2.php?id=35810059&s=flu&pm=2
Share: http://m.amedeo.com/35810059
29. WONG SC, Chan VW, Lam GKM, Yuen LL, et al.
The impact of personal coaching on influenza vaccination among healthcare workers
before and during COVID-19 pandemic.
Vaccine. 2022 Jun 27. pii: S0264-410X(22)00836.
PubMed: http://www.amedeo.com/p2.php?id=35810057&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35810057
Share this:
Influenza and COVID19 Research References (by AMEDEO, June 25 ’22)
1. CACERES J, Maki DG, Hennekens CH.
Cautious Optimism and Considerations for Health Providers and Patients: Oral
Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention
of COVID-19.
Am J Med. 2022;135:808-809.
PubMed: http://www.amedeo.com/p2.php?id=35307362&s=flu&pm=2
Share: http://m.amedeo.com/35307362
2. LI W, Rios S, Nagraj S, Hajra A, et al.
Statin Use in Hospitalized Patients with COVID-19: A Comprehensive Analysis of
the New York City Public Hospital System.
Am J Med. 2022;135:897-905.
PubMed: http://www.amedeo.com/p2.php?id=35296403&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35296403
3. COHEN A.
Concerns About Our Public Medical Response to COVID 19.
Am J Med. 2022;135:801-802.
PubMed: http://www.amedeo.com/p2.php?id=35263636&s=flu&pm=2
Share: http://m.amedeo.com/35263636
4. SMITH CA, Barnes GD.
Web Exclusive. Annals for Hospitalists Inpatient Notes – Venous Thromboembolism
Prophylaxis in COVID-19: Making Sense of the Evidence.
Ann Intern Med. 2022;175:HO2-HO3.
PubMed: http://www.amedeo.com/p2.php?id=35724407&s=flu&pm=2
Share: http://m.amedeo.com/35724407
5. KING D.
Patients surviving COVID-19 had increased risk for adverse mental health outcomes
vs. persons without COVID-19.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0031.
PubMed: http://www.amedeo.com/p2.php?id=35667077&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35667077
6. SHAH A, O’Horo JC.
In patients with COVID-19 receiving IMV or ECMO, adding baricitinib to usual care
reduced all-cause mortality.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0033.
PubMed: http://www.amedeo.com/p2.php?id=35667076&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35667076
7. VASSILOPOULOS A, Mylonakis E.
In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir
reduced hospitalization or death.
Ann Intern Med. 2022 Jun 7. doi: 10.7326/J22-0038.
PubMed: http://www.amedeo.com/p2.php?id=35667068&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35667068
8. ASSOUMOU SA, Peterson A, Ginman E, James T, et al.
Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center
Health System Experience.
Ann Intern Med. 2022 May 17. doi: 10.7326/M22-0028.
PubMed: http://www.amedeo.com/p2.php?id=35576586&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35576586
9. MULL MCCRARY M.
Web Exclusive. Annals Story Slam – A Two-Year Long Blackjack Game: Decisions
During COVID.
Ann Intern Med. 2022;175:SS1.
PubMed: http://www.amedeo.com/p2.php?id=35486152&s=flu&pm=2
Share: http://m.amedeo.com/35486152
10. OHN-SAITH MAS.
Annals Story Slam – Three-Finger Salute to the COVID-19 Pandemic.
Ann Intern Med. 2022 Apr 29:SS1. doi: 10.7326/W22-0010.
PubMed: http://www.amedeo.com/p2.php?id=35486142&s=flu&pm=2
Share: http://m.amedeo.com/35486142
11. CLARKE SR.
Web Exclusive. Annals Story Slam – The Prayer in the COVID Unit.
Ann Intern Med. 2022;175:SS1.
PubMed: http://www.amedeo.com/p2.php?id=35486116&s=flu&pm=2
Share: http://m.amedeo.com/35486116
12. KOTTON CN.
Belt and Suspenders: Vaccines and Tixagevimab/Cilgavimab for Prevention of
COVID-19 in Immunocompromised Patients.
Ann Intern Med. 2022 Apr 12. doi: 10.7326/M22-1026.
PubMed: http://www.amedeo.com/p2.php?id=35404669&s=flu&pm=2
Share: http://m.amedeo.com/35404669
13. NUSSBAUM EZ, Thiriveedhi V, Uddin R, Cho HE, et al.
Implementation of a SARS-CoV-2 Genotyping Panel for Prompt Omicron Variant
Identification: A Pragmatic Tool for Clinical Laboratories.
Ann Intern Med. 2022 Mar 29. doi: 10.7326/M22-0023.
PubMed: http://www.amedeo.com/p2.php?id=35344374&s=flu&pm=2
Share: http://m.amedeo.com/35344374
14. BOUZID D, Visseaux B, Kassasseya C, Daoud A, et al.
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants
Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
Ann Intern Med. 2022 Mar 15. doi: 10.7326/M22-0308.
PubMed: http://www.amedeo.com/p2.php?id=35286147&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35286147
15. Summary for Patients: Comparison of Patients Infected With Delta Versus Omicron
COVID-19 Variants Presenting to Paris Emergency Departments.
Ann Intern Med. 2022 Mar 15. doi: 10.7326/P22-0005.
PubMed: http://www.amedeo.com/p2.php?id=35286145&s=flu&pm=2
Share: http://m.amedeo.com/35286145
16. JONES JC, Rovito SW, Penaflor MK, Webby RJ, et al.
Influenza A virus polymerase acidic protein E23R substitution is a marker of
reduced susceptibility to baloxavir.
Antiviral Res. 2022 Jun 20:105369. doi: 10.1016/j.antiviral.2022.105369.
PubMed: http://www.amedeo.com/p2.php?id=35738347&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35738347
17. SCOBIE S.
Covid-19: How has the pandemic differed across the four UK nations?
BMJ. 2022;377:o1482.
PubMed: http://www.amedeo.com/p2.php?id=35732314&s=flu&pm=2
Share: http://m.amedeo.com/35732314
18. LI X, Ostropolets A, Makadia R, Shoaibi A, et al.
Characterising the background incidence rates of adverse events of special
interest for covid-19 vaccines in eight countries: multinational network cohort
study.
BMJ. 2021;373:n1435.
PubMed: http://www.amedeo.com/p2.php?id=35727911&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35727911
19. WISE J.
Covid-19: Omicron sub variants driving new wave of infections in UK.
BMJ. 2022;377:o1506.
PubMed: http://www.amedeo.com/p2.php?id=35724993&s=flu&pm=2
Share: http://m.amedeo.com/35724993
20. TANNE JH.
Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s.
BMJ. 2022;377:o1507.
PubMed: http://www.amedeo.com/p2.php?id=35724985&s=flu&pm=2
Share: http://m.amedeo.com/35724985
21. WISE J.
Covid-19: Long covid risk is lower with omicron than delta, researchers find.
BMJ. 2022;377:o1500.
PubMed: http://www.amedeo.com/p2.php?id=35714995&s=flu&pm=2
Share: http://m.amedeo.com/35714995
22. PAGEL C.
The covid waves continue to come.
BMJ. 2022;377:o1504.
PubMed: http://www.amedeo.com/p2.php?id=35714983&s=flu&pm=2
Share: http://m.amedeo.com/35714983
23. WISE J.
Covid-19: Omicron infection is poor booster to immunity, study finds.
BMJ. 2022;377:o1474.
PubMed: http://www.amedeo.com/p2.php?id=35705220&s=flu&pm=2
Share: http://m.amedeo.com/35705220
24. ADAB P, Haroon S, O’Hara ME, Jordan RE, et al.
Comorbidities and covid-19.
BMJ. 2022;377:o1431.
PubMed: http://www.amedeo.com/p2.php?id=35705219&s=flu&pm=2
Share: http://m.amedeo.com/35705219
25. WEI W, Kong N, Liu MZ, Han T, et al.
Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main
protease.
Biochem Biophys Res Commun. 2022;616:8-13.
PubMed: http://www.amedeo.com/p2.php?id=35636257&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35636257
26. ZHANG B, Li Y, Feng Q, Song L, et al.
Structural insights into ORF10 recognition by ZYG11B.
Biochem Biophys Res Commun. 2022;616:14-18.
PubMed: http://www.amedeo.com/p2.php?id=35636250&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35636250
27. SUGAMOTO K, Tanaka YL, Saito A, Goto Y, et al.
Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and
stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral
3CLpro enzymes.
Biochem Biophys Res Commun. 2022;615:56-62.
PubMed: http://www.amedeo.com/p2.php?id=35605406&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35605406
28. DEN BOOGERT EM, de Lange MMA, Wielders CCH, Rietveld A, et al.
Incidence and severity of SARS-CoV-2 infection in former Q fever patients as
compared to the Dutch population, 2020-2021.
Epidemiol Infect. 2022;150:e116.
PubMed: http://www.amedeo.com/p2.php?id=35730315&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35730315
29. RAY I, Hasan MM, Shah PA, Sahito AM, et al.
HIV epidemic amidst COVID-19 pandemic in India: a conundrum for the country’s
healthcare system.
Epidemiol Infect. 2022;150:e112.
PubMed: http://www.amedeo.com/p2.php?id=35615920&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35615920
30. XU X, Zhang K, Ma H, Shen X, et al.
Differences in service and antibiotics use following symptomatic respiratory
tract infections between 2016 and 2021 in rural Anhui, China.
Epidemiol Infect. 2022;150:e117.
PubMed: http://www.amedeo.com/p2.php?id=35610736&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35610736
31. THOMAS DR, Fina LH, Adamson JP, Sawyer C, et al.
Social, demographic and behavioural determinants of SARS-CoV-2 infection: a
case-control study carried out during mass community testing of asymptomatic
individuals in South Wales, December 2020.
Epidemiol Infect. 2022;150:e115.
PubMed: http://www.amedeo.com/p2.php?id=35535456&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35535456
32. VERBERK JDM, de Hoog MLA, Westerhof I, van Goethem S, et al.
Transmission of SARS-CoV-2 within households: a remote prospective cohort study
in European countries.
Eur J Epidemiol. 2022;37:549-561.
PubMed: http://www.amedeo.com/p2.php?id=35644003&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35644003
33. CASPERSEN IH, Magnus P, Trogstad L.
Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
Eur J Epidemiol. 2022;37:539-548.
PubMed: http://www.amedeo.com/p2.php?id=35211871&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35211871
34. RODINO KG, Peaper DR, Kelly BJ, Bushman F, et al.
Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1.
J Clin Microbiol. 2022;60:e0060022.
PubMed: http://www.amedeo.com/p2.php?id=35582905&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35582905
35. DESCHERMEIER C, Ehmen C, von Possel R, Murawski C, et al.
Fcgamma-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive,
Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG
Antibodies in Human Sera.
J Clin Microbiol. 2022;60:e0007522.
PubMed: http://www.amedeo.com/p2.php?id=35574677&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35574677
36. MISRA A, Theel ES.
Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
J Clin Microbiol. 2022;60:e0048221.
PubMed: http://www.amedeo.com/p2.php?id=35249377&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35249377
37. ZHANG Q, Matuozzo D, Le Pen J, Lee D, et al.
Recessive inborn errors of type I IFN immunity in children with COVID-19
pneumonia.
J Exp Med. 2022;219.
PubMed: http://www.amedeo.com/p2.php?id=35708626&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35708626
38. PLANCHAIS C, Fernandez I, Bruel T, de Melo GD, et al.
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective
against Omicron BA.1 and BA.2.
J Exp Med. 2022;219.
PubMed: http://www.amedeo.com/p2.php?id=35704748&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35704748
39. ACOSTA-AMPUDIA Y, Monsalve DM, Rojas M, Rodriguez Y, et al.
Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus
Disease 2019 Syndrome.
J Infect Dis. 2022;225:2155-2162.
PubMed: http://www.amedeo.com/p2.php?id=35079804&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35079804
40. VEDHARA K, Ayling K, Jia R, Fairclough L, et al.
Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute
Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept.
J Infect Dis. 2022;225:2137-2141.
PubMed: http://www.amedeo.com/p2.php?id=35022740&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35022740
41. TURNBULL J, Jha RR, Ortori CA, Lunt E, et al.
Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving
Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome
Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response.
J Infect Dis. 2022;225:2142-2154.
PubMed: http://www.amedeo.com/p2.php?id=34979019&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34979019
42. CHANG YH, Kao CC, Fang JJ, Lee YH, et al.
Correspondence to Morbidity and Mortality Among Adults Experiencing Homelessness
Hospitalized With Coronavirus Disease 2019.
J Infect Dis. 2022;225:2235.
PubMed: http://www.amedeo.com/p2.php?id=34951649&s=flu&pm=2
Share: http://m.amedeo.com/34951649
43. PHIJFFER EWEM, Bont LJ.
Are we ready for maternal RSV vaccination?
J Infect Dis. 2021 Dec 21. pii: 6472740. doi: 10.1093.
PubMed: http://www.amedeo.com/p2.php?id=34932123&s=flu&pm=2
Share: http://m.amedeo.com/34932123
44. PETERSON JT, Zareba AM, Fitz-Patrick D, Essink BJ, et al.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine
When Co-Administered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
J Infect Dis. 2021 Oct 12. pii: 6391485. doi: 10.1093.
PubMed: http://www.amedeo.com/p2.php?id=34637519&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34637519
45. SCHWARZ TF, Johnson C, Grigat C, Apter D, et al.
Three dose levels of a maternal respiratory syncytial virus vaccine candidate are
well tolerated and immunogenic in a randomized trial in non-pregnant women.
J Infect Dis. 2021 Jun 19. pii: 6306104. doi: 10.1093.
PubMed: http://www.amedeo.com/p2.php?id=34146100&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34146100
46. DEVINCENZO J, Cass L, Murray A, Woodward K, et al.
Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus
Challenge Study.
J Infect Dis. 2022;225:2087-2096.
PubMed: http://www.amedeo.com/p2.php?id=33216113&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/33216113
47. NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al.
The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of
Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western
Kenya.
J Infect Dis. 2022;225:2097-2105.
PubMed: http://www.amedeo.com/p2.php?id=32777041&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/32777041
48. LIU H, Bai Y, Zhang X, Gao T, et al.
SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by
Interacting with G3BPs to Facilitate Viral Replication.
J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
PubMed: http://www.amedeo.com/p2.php?id=35652658&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35652658
49. RUBIN R.
Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
JAMA. 2022;327:2281.
PubMed: http://www.amedeo.com/p2.php?id=35727290&s=flu&pm=2
Share: http://m.amedeo.com/35727290
50. LARKIN HD.
mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
JAMA. 2022;327:2280.
PubMed: http://www.amedeo.com/p2.php?id=35727270&s=flu&pm=2
Share: http://m.amedeo.com/35727270
51. LARKIN HD.
Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
JAMA. 2022;327:2182.
PubMed: http://www.amedeo.com/p2.php?id=35699722&s=flu&pm=2
Share: http://m.amedeo.com/35699722
52. LARKIN HD.
Urine Test Detects SARS-CoV-2 Antibodies.
JAMA. 2022;327:2182.
PubMed: http://www.amedeo.com/p2.php?id=35699720&s=flu&pm=2
Share: http://m.amedeo.com/35699720
53. FARMAKIOTIS D.
COVID-19 Treatments for Nonhospitalized Patients.
JAMA. 2022;327:2247.
PubMed: http://www.amedeo.com/p2.php?id=35699710&s=flu&pm=2
Share: http://m.amedeo.com/35699710
54. CAYLEY WE JR.
COVID-19 Treatments for Nonhospitalized Patients.
JAMA. 2022;327:2248.
PubMed: http://www.amedeo.com/p2.php?id=35699709&s=flu&pm=2
Share: http://m.amedeo.com/35699709
55. GANDHI RT, Malani PN, Del Rio C.
COVID-19 Treatments for Nonhospitalized Patients-Reply.
JAMA. 2022;327:2248.
PubMed: http://www.amedeo.com/p2.php?id=35699707&s=flu&pm=2
Share: http://m.amedeo.com/35699707
56. RUBIN R.
Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect
Against Variants.
JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
PubMed: http://www.amedeo.com/p2.php?id=35648442&s=flu&pm=2
Share: http://m.amedeo.com/35648442
57. RUBIN R.
SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus.
JAMA. 2022 May 18. pii: 2792688. doi: 10.1001/jama.2022.7892.
PubMed: http://www.amedeo.com/p2.php?id=35583898&s=flu&pm=2
Share: http://m.amedeo.com/35583898
58. BELLANDI D, Voelker R.
New White House COVID-19 Leader on What’s Next.
JAMA. 2022 May 18. pii: 2792686. doi: 10.1001/jama.2022.8541.
PubMed: http://www.amedeo.com/p2.php?id=35583895&s=flu&pm=2
Share: http://m.amedeo.com/35583895
59. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al.
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2
Infection in Children and Adolescents During Omicron Predominance.
JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
PubMed: http://www.amedeo.com/p2.php?id=35560036&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35560036
60. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al.
Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged
18 to 49 Years by Key Demographics.
JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
PubMed: http://www.amedeo.com/p2.php?id=35452085&s=flu&pm=2
Share: http://m.amedeo.com/35452085
61. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al.
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
Lancet. 2022;399:2263-2264.
PubMed: http://www.amedeo.com/p2.php?id=35717982&s=flu&pm=2
Share: http://m.amedeo.com/35717982
62. OFRI D.
Memorialising COVID-19.
Lancet. 2022;399:2260-2261.
PubMed: http://www.amedeo.com/p2.php?id=35717980&s=flu&pm=2
Share: http://m.amedeo.com/35717980
63. KAMBHAMPATI AK, Burke RM, Dietz S, Sheppard M, et al.
Trends in Acute Hepatitis of Unspecified Etiology and Adenovirus Stool Testing
Results in Children – United States, 2017-2022.
MMWR Morb Mortal Wkly Rep. 2022;71:797-802.
PubMed: http://www.amedeo.com/p2.php?id=35709071&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35709071
64. LEE D, Counard C, Tang A, Brister S, et al.
Notes from the Field: COVID-19-Associated Mortality Risk Among Long-Term Care
Facility Residents and Community-Dwelling Adults Aged >/=65 Years – Illinois,
December 2020 and January 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:803-805.
PubMed: http://www.amedeo.com/p2.php?id=35709016&s=flu&pm=2
Share: http://m.amedeo.com/35709016
65. YUAN Y, Thierry JM, Bull-Otterson L, Yeargin-Allsopp M, et al.
COVID-19 Cases and Hospitalizations Among Medicare Beneficiaries With and Without
Disabilities – United States, January 1, 2020-November 20, 2021.
MMWR Morb Mortal Wkly Rep. 2022;71:791-796.
PubMed: http://www.amedeo.com/p2.php?id=35709015&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35709015
66. RUBIN EJ, Baden LR, Morrissey S.
Audio Interview: Vaccinating Young Children against Covid-19.
N Engl J Med. 2022;386:e77.
PubMed: http://www.amedeo.com/p2.php?id=35731664&s=flu&pm=2
Share: http://m.amedeo.com/35731664
67. GRIFFIN MR.
A Challenge to Respiratory Syncytial Virus Illness in Adults.
N Engl J Med. 2022;386:2427-2428.
PubMed: http://www.amedeo.com/p2.php?id=35731658&s=flu&pm=2
Share: http://m.amedeo.com/35731658
68. SCHMOELE-THOMA B, Zareba AM, Jiang Q, Maddur MS, et al.
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med. 2022;386:2377-2386.
PubMed: http://www.amedeo.com/p2.php?id=35731653&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35731653
69. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al.
Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
N Engl J Med. 2022;386:e75.
PubMed: http://www.amedeo.com/p2.php?id=35704488&s=flu&pm=2
Share: http://m.amedeo.com/35704488
70. JOLOBE OMP.
Protection Due to Previous SARS-CoV-2 Infection.
N Engl J Med. 2022;386.
PubMed: http://www.amedeo.com/p2.php?id=35675204&s=flu&pm=2
Share: http://m.amedeo.com/35675204
71. SCHERER EM, Babiker A, Adelman MW, Allman B, et al.
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
N Engl J Med. 2022 Jun 8. doi: 10.1056/NEJMc2202861.
PubMed: http://www.amedeo.com/p2.php?id=35675197&s=flu&pm=2
Share: http://m.amedeo.com/35675197
72. ACCORSI EK, Britton A, Shang N, Fleming-Dutra KE, et al.
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
N Engl J Med. 2022 May 25. doi: 10.1056/NEJMc2203165.
PubMed: http://www.amedeo.com/p2.php?id=35613039&s=flu&pm=2
Share: http://m.amedeo.com/35613039
73. BROWN PE, Fu SH, Bansal A, Newcombe L, et al.
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.
N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2202879.
PubMed: http://www.amedeo.com/p2.php?id=35584302&s=flu&pm=2
Share: http://m.amedeo.com/35584302
74. EVANS JP, Qu P, Zeng C, Zheng YM, et al.
Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants.
N Engl J Med. 2022 May 18. doi: 10.1056/NEJMc2205019.
PubMed: http://www.amedeo.com/p2.php?id=35584183&s=flu&pm=2
Share: http://m.amedeo.com/35584183
75. DIEDERICHS M, van Ewijk R, Isphording IE, Pestel N, et al.
Schools under mandatory testing can mitigate the spread of SARS-CoV-2.
Proc Natl Acad Sci U S A. 2022;119:e2201724119.
PubMed: http://www.amedeo.com/p2.php?id=35733261&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35733261
76. HU M, Qiu Z, Bi Z, Tian T, et al.
Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics.
Proc Natl Acad Sci U S A. 2022;119:e2202034119.
PubMed: http://www.amedeo.com/p2.php?id=35727982&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35727982
77. SHEN Y, Courtney JM, Anfinrud P, Bax A, et al.
Hybrid measurement of respiratory aerosol reveals a dominant coarse fraction
resulting from speech that remains airborne for minutes.
Proc Natl Acad Sci U S A. 2022;119:e2203086119.
PubMed: http://www.amedeo.com/p2.php?id=35727979&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35727979
78. LIMA DE MIRANDA K, Snower DJ.
The societal responses to COVID-19: Evidence from the G7 countries.
Proc Natl Acad Sci U S A. 2022;119:e2117155119.
PubMed: http://www.amedeo.com/p2.php?id=35714290&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35714290
79. QIN C, Rao Y, Yuan H, Wang TY, et al.
SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide
synthesis.
Proc Natl Acad Sci U S A. 2022;119:e2122897119.
PubMed: http://www.amedeo.com/p2.php?id=35700355&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35700355
80. CANADAY LM, Resnick JD, Liu H, Powell H, et al.
HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza
vaccine infection in human nasal epithelial cell cultures.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00733.
PubMed: http://www.amedeo.com/p2.php?id=35718589&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35718589
81. BRAUNFELD JB, Carson HN, Williams SR, Schwartz LM, et al.
Clinical endpoints to inform vaccine policy: A systematic review of outcome
measures from pediatric influenza vaccine efficacy trials.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00778.
PubMed: http://www.amedeo.com/p2.php?id=35717265&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35717265
82. MOGHNIEH R, Abdallah D, Sayegh MH, Rahman Bizri A, et al.
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine
design.
Vaccine. 2022;40:3987-3988.
PubMed: http://www.amedeo.com/p2.php?id=35717109&s=flu&pm=2
Share: http://m.amedeo.com/35717109
83. CIMOLAI N.
Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3985-3986.
PubMed: http://www.amedeo.com/p2.php?id=35717108&s=flu&pm=2
Share: http://m.amedeo.com/35717108
84. CHUNG JR, Kim SS, Flannery B, Smith ME, et al.
Vaccine-associated attenuation of subjective severity among outpatients with
influenza.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00767.
PubMed: http://www.amedeo.com/p2.php?id=35710506&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35710506
85. ZHAO FJ, Liu LT, Wang Z, Wang NX, et al.
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated
vaccine with different adjuvants in mice.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00721.
PubMed: http://www.amedeo.com/p2.php?id=35691873&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35691873
86. HASHIMOTO M, Nagata N, Homma T, Maeda H, et al.
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein
vaccine S-268019-b in cynomolgus monkeys.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00718.
PubMed: http://www.amedeo.com/p2.php?id=35691872&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35691872
87. EUGENIA-TOLEDO-ROMANI M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al.
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or
heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00717.
PubMed: http://www.amedeo.com/p2.php?id=35691871&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35691871
88. TOOR J, Li X, Jit M, Trotter CL, et al.
COVID-19 impact on routine immunisations for vaccine-preventable diseases:
Projecting the effect of different routes to recovery.
Vaccine. 2022 May 30. pii: S0264-410X(22)00698.
PubMed: http://www.amedeo.com/p2.php?id=35672179&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35672179
89. WOO EJ, Dimova RB.
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine
adverse event reporting system.
Vaccine. 2022 May 30. pii: S0264-410X(22)00704.
PubMed: http://www.amedeo.com/p2.php?id=35667915&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35667915
90. NOWALK MP, D’Agostino H, Dauer K, Stiegler M, et al.
Estimating the burden of adult hospitalized RSV infection including special
populations.
Vaccine. 2022;40:4121-4127.
PubMed: http://www.amedeo.com/p2.php?id=35667912&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35667912
91. PATEL KM, Shafiq M, Malik AA, Cobanoglu A, et al.
Relationship between the use of nonpharmaceutical interventions and COVID-19
vaccination among U.S. child care providers: A prospective cohort study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00680.
PubMed: http://www.amedeo.com/p2.php?id=35660329&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35660329
92. WILSON B, Mukundan Geetha K.
Nanomedicine to deliver biological macromolecules for treating COVID-19.
Vaccine. 2022;40:3931-3941.
PubMed: http://www.amedeo.com/p2.php?id=35660038&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35660038
93. MERRICK E, Weissman JP, Patel SJ.
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies.
Vaccine. 2022 May 30. pii: S0264-410X(22)00699.
PubMed: http://www.amedeo.com/p2.php?id=35660035&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35660035
94. SOEGIARTO G, Wulandari L, Purnomosari D, Dhia Fahmita K, et al.
Hypertension is associated with antibody response and breakthrough infection in
health care workers following vaccination with inactivated SARS-CoV-2.
Vaccine. 2022 May 27. pii: S0264-410X(22)00676.
PubMed: http://www.amedeo.com/p2.php?id=35660034&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35660034
95. SALMANTON-GARCIA J, Stewart FA, Heringer S, Koniordou M, et al.
VACCELERATE Volunteer Registry: A European study participant database to
facilitate clinical trial enrolment.
Vaccine. 2022;40:4090-4097.
PubMed: http://www.amedeo.com/p2.php?id=35659449&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35659449
96. DUBE C, Paris-Robidas S, Andreani G, Gutzeit C, et al.
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351
AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.
Vaccine. 2022 May 27. pii: S0264-410X(22)00641.
PubMed: http://www.amedeo.com/p2.php?id=35654621&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35654621
97. LEIGH JP, Moss SJ, White TM, Picchio CA, et al.
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23
countries.
Vaccine. 2022 May 5. pii: S0264-410X(22)00545.
PubMed: http://www.amedeo.com/p2.php?id=35654620&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35654620
98. SHAPIRO BEN DAVID S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, et al.
Robust antibody response after a third BNT162b2 vaccine compared to the second
among immunocompromised and healthy individuals, a prospective longitudinal
cohort study.
Vaccine. 2022 May 28. pii: S0264-410X(22)00668.
PubMed: http://www.amedeo.com/p2.php?id=35641358&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35641358
99. DUBE E, Gagnon D, MacDonald N.
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.
Vaccine. 2022 May 25. pii: S0264-410X(22)00670.
PubMed: http://www.amedeo.com/p2.php?id=35637068&s=flu&pm=2
Share: http://m.amedeo.com/35637068
100. BECK E, Biundo E, Devlin N, Doherty TM, et al.
Capturing the value of vaccination within health technology assessment and health
economics: Literature review and novel conceptual framework.
Vaccine. 2022 May 23. pii: S0264-410X(22)00490.
PubMed: http://www.amedeo.com/p2.php?id=35618559&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35618559
101. LEEGWATER E, Moes DJAR, Bosma LBE, Ottens TH, et al.
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19
Patients.
Antimicrob Agents Chemother. 2022;66:e0025422.
PubMed: http://www.amedeo.com/p2.php?id=35647646&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35647646
102. PITTS J, Li J, Perry JK, Du Pont V, et al.
Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and
Other Emergent SARS-CoV-2 Variants.
Antimicrob Agents Chemother. 2022;66:e0022222.
PubMed: http://www.amedeo.com/p2.php?id=35532238&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35532238
Share this:
Influenza and COVID19 Research References (by AMEDEO, May 28 ’22)
1. WISE J.
Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study
finds.
BMJ. 2022;377:o1305.
PubMed: http://www.amedeo.com/p2.php?id=35609918&s=flu&pm=2
Share: http://m.amedeo.com/35609918
2. SALISBURY H.
Helen Salisbury: Living under the long shadow of covid.
BMJ. 2022;377:o1288.
PubMed: http://www.amedeo.com/p2.php?id=35609900&s=flu&pm=2
Share: http://m.amedeo.com/35609900
3. GAZIT S, Saciuk Y, Perez G, Peretz A, et al.
Short term, relative effectiveness of four doses versus three doses of BNT162b2
vaccine in people aged 60 years and older in Israel: retrospective, test
negative, case-control study.
BMJ. 2022;377:e071113.
PubMed: http://www.amedeo.com/p2.php?id=35609888&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35609888
4. LIMB M.
Covid-19: Doctors’ wellbeing must be “critical priority” after pandemic mistakes,
says BMA.
BMJ. 2022;377:o1284.
PubMed: http://www.amedeo.com/p2.php?id=35605996&s=flu&pm=2
Share: http://m.amedeo.com/35605996
5. HORDIJK L, Patnaik P.
Covid-19-How Europe’s vaccine donations went tragically wrong.
BMJ. 2022;377:o1286.
PubMed: http://www.amedeo.com/p2.php?id=35605988&s=flu&pm=2
Share: http://m.amedeo.com/35605988
6. TANNE JH.
Covid-19: Sexually transmitted diseases surged in US during pandemic.
BMJ. 2022;377:o1275.
PubMed: http://www.amedeo.com/p2.php?id=35595288&s=flu&pm=2
Share: http://m.amedeo.com/35595288
7. WISE J.
Covid-19: JCVI advises further booster for vulnerable adults and health and care
workers.
BMJ. 2022;377:o1277.
PubMed: http://www.amedeo.com/p2.php?id=35595269&s=flu&pm=2
Share: http://m.amedeo.com/35595269
8. MAHASE E.
Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact
for others, says WHO.
BMJ. 2022;377:o1259.
PubMed: http://www.amedeo.com/p2.php?id=35589118&s=flu&pm=2
Share: http://m.amedeo.com/35589118
9. IACOBUCCI G.
Covid-19: Government failed to protect doctors during pandemic, BMA inquiry
finds.
BMJ. 2022;377:o1235.
PubMed: http://www.amedeo.com/p2.php?id=35589117&s=flu&pm=2
Share: http://m.amedeo.com/35589117
10. Caught on film: NHS life during the pandemic.
BMJ. 2022;377:o1224.
PubMed: http://www.amedeo.com/p2.php?id=35589111&s=flu&pm=2
Share: http://m.amedeo.com/35589111
11. TANNE JH.
Covid-19: US hospitals continued to perform unnecessary surgeries during
pandemic.
BMJ. 2022;377:o1254.
PubMed: http://www.amedeo.com/p2.php?id=35589108&s=flu&pm=2
Share: http://m.amedeo.com/35589108
12. WONG JY, Cheung CM, Bond HS, Cheung JK, et al.
Estimating excess septicaemia mortality and hospitalisation burden associated
with influenza in Hong Kong, 1998 to 2019.
Epidemiol Infect. 2022;150:e101.
PubMed: http://www.amedeo.com/p2.php?id=35606895&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35606895
13. SHINGLETON J, Finnie T, Gent N, Bennett E, et al.
Assessing the role of imported cases on the establishment of SARS-CoV-2 Delta
variant of concern in Bolton, UK.
Epidemiol Infect. 2022;150:e100.
PubMed: http://www.amedeo.com/p2.php?id=35545847&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35545847
14. HIIRONEN I, Saavedra-Campos M, Panitz J, Ma T, et al.
Workplace exposures associated with COVID-19: evidence from a case-control study
with multiple sampling periods in England, August-October 2020.
Epidemiol Infect. 2022;150:e99.
PubMed: http://www.amedeo.com/p2.php?id=35545421&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35545421
15. WARE CF, Croft M, Neil GA.
Realigning the LIGHT signaling network to control dysregulated inflammation.
J Exp Med. 2022;219.
PubMed: http://www.amedeo.com/p2.php?id=35604387&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35604387
16. DE MOOR WRJ, Regnard GL, Rybicki EP, Williamson AL, et al.
Characterization of a dynamic self-replicating mammalian expression vector based
on the circular ssDNA genome of beak and feather disease virus.
J Gen Virol. 2022;103.
PubMed: http://www.amedeo.com/p2.php?id=35594121&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35594121
17. JERGOVIC M, Coplen CP, Uhrlaub JL, Beitel SC, et al.
Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced
by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.
J Immunol. 2022;208:2461-2465.
PubMed: http://www.amedeo.com/p2.php?id=35562119&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35562119
18. LI Y, Wei L, He L, Sun J, et al.
Interferon-induced transmembrane protein 3 gene polymorphisms are associated with
COVID-19 susceptibility and severity: A meta-analysis.
J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
PubMed: http://www.amedeo.com/p2.php?id=35461906&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35461906
19. WHITAKER H, Tsang RS, Button E, Andrews N, et al.
Sociodemographic disparities in COVID-19 seroprevalence across England in the
Oxford RCGP primary care sentinel network.
J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
PubMed: http://www.amedeo.com/p2.php?id=35405169&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35405169
20. LIU X, Munro APS, Feng S, Janani L, et al.
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose
boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three
month analyses of the COV-BOOST trial.
J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
PubMed: http://www.amedeo.com/p2.php?id=35405168&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35405168
21. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al.
Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate
COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.
PubMed: http://www.amedeo.com/p2.php?id=35398409&s=flu&pm=2
Share: http://m.amedeo.com/35398409
22. BADDAL B, Bostanci A.
The impact of COVID-19 on the molecular epidemiology of seasonal viral
respiratory infections, Cyprus.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.
PubMed: http://www.amedeo.com/p2.php?id=35398407&s=flu&pm=2
Share: http://m.amedeo.com/35398407
23. CHENG CY, Hsiao SH, Fang TC, Lin YC, et al.
SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19
and Moderna Vaccine in Chronic Dialysis Patients.
J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.
PubMed: http://www.amedeo.com/p2.php?id=35398405&s=flu&pm=2
Share: http://m.amedeo.com/35398405
24. YOON JG, Yoo JS, Lee J, Hyun HJ, et al.
Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.
PubMed: http://www.amedeo.com/p2.php?id=35351541&s=flu&pm=2
Share: http://m.amedeo.com/35351541
25. MENG J, Ge Q, Li J, Lu X, et al.
Protective trend of anti-androgen therapy during the COVID-19 pandemic: a
meta-analysis.
J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.
PubMed: http://www.amedeo.com/p2.php?id=35341831&s=flu&pm=2
Share: http://m.amedeo.com/35341831
26. SCHILDGEN V, Lusebrink J, Schildgen O.
Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not
replace personal protection measures while dealing with vulnarable individuals.
J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.
PubMed: http://www.amedeo.com/p2.php?id=35339503&s=flu&pm=2
Share: http://m.amedeo.com/35339503
27. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al.
Elevated neutralization of Omicron with sera of COVID-19 recovered and
breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.
PubMed: http://www.amedeo.com/p2.php?id=35318093&s=flu&pm=2
Share: http://m.amedeo.com/35318093
28. MURGIA F, Fiamma M, Serra S, Olla S, et al.
The impact of secondary infections in COVID-19 critically ill patients.
J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.
PubMed: http://www.amedeo.com/p2.php?id=35314266&s=flu&pm=2
Share: http://m.amedeo.com/35314266
29. DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al.
Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and
BA.2 sub-variants.
J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.
PubMed: http://www.amedeo.com/p2.php?id=35307410&s=flu&pm=2
Share: http://m.amedeo.com/35307410
30. AO G, Wang Y, Li A, Tran C, et al.
The effect of canakinumab on clinical outcomes in patients with COVID-19: a
meta-analysis.
J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.
PubMed: http://www.amedeo.com/p2.php?id=35301014&s=flu&pm=2
Share: http://m.amedeo.com/35301014
31. CHEN C, Tang J, Wang C, Wen W, et al.
Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients
Discharged.
J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.
PubMed: http://www.amedeo.com/p2.php?id=35283185&s=flu&pm=2
Share: http://m.amedeo.com/35283185
32. FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al.
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using
neutralization and specific ELISA assays.
J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.
PubMed: http://www.amedeo.com/p2.php?id=35278483&s=flu&pm=2
Share: http://m.amedeo.com/35278483
33. GIMENEZ E, Albert E, Burgos JS, Peiro S, et al.
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after
two doses of the Comirnaty(R) COVID-19 vaccine.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
PubMed: http://www.amedeo.com/p2.php?id=35245583&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35245583
34. BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al.
SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.
PubMed: http://www.amedeo.com/p2.php?id=35245582&s=flu&pm=2
Share: http://m.amedeo.com/35245582
35. SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr.
Effectiveness of COVID-19 vaccines in Qatar.
J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.
PubMed: http://www.amedeo.com/p2.php?id=35245580&s=flu&pm=2
Share: http://m.amedeo.com/35245580
36. HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al.
Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or
ChAdOx1 and Heterologous Third Dose with BNT162b2.
J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.
PubMed: http://www.amedeo.com/p2.php?id=35235810&s=flu&pm=2
Share: http://m.amedeo.com/35235810
37. KONIG S, Hohenstein S, Leiner J, Hindricks G, et al.
National mortality data for Germany before and throughout the pandemic: there is
an excess mortality exceeding COVID-19-attributed fatalities.
J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.
PubMed: http://www.amedeo.com/p2.php?id=35231486&s=flu&pm=2
Share: http://m.amedeo.com/35231486
38. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al.
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.
PubMed: http://www.amedeo.com/p2.php?id=35231485&s=flu&pm=2
Share: http://m.amedeo.com/35231485
39. SAEED A, Ahmad B, Majaz S, Nouroz F, et al.
Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of
Main Protease 3CL Mpro: Molecular Simulation Analysis.
J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.
PubMed: http://www.amedeo.com/p2.php?id=35183608&s=flu&pm=2
Share: http://m.amedeo.com/35183608
40. ZHENG J, Wang Z, Li J, Zhang Y, et al.
High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant
infection.
J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.
PubMed: http://www.amedeo.com/p2.php?id=35183607&s=flu&pm=2
Share: http://m.amedeo.com/35183607
41. KWOK KO, Wei WI, Ma BHM, Ip M, et al.
Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.
PubMed: http://www.amedeo.com/p2.php?id=35183606&s=flu&pm=2
Share: http://m.amedeo.com/35183606
42. ZHENG H, Ma L, Gui R, Lin X, et al.
G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting
the Nuclear Import of PB2.
J Virol. 2022 May 23:e0049422. doi: 10.1128/jvi.00494.
PubMed: http://www.amedeo.com/p2.php?id=35604143&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35604143
43. DE OLIVEIRA PSS, de Oliveira Silva B, E Silva RP, Galdino LV, et al.
Evaluation of long-term stability of SARS-CoV-2 nucleic acid extracted from human
nasopharyngeal samples.
J Virol Methods. 2022;305:114529.
PubMed: http://www.amedeo.com/p2.php?id=35398116&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35398116
44. WEISS SR.
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
JAMA. 2022;327:2019-2020.
PubMed: http://www.amedeo.com/p2.php?id=35608592&s=flu&pm=2
Share: http://m.amedeo.com/35608592
45. PEREZ-FERNANDEZ XL, Fuset-Cabanes M, Hernandez-Platero L.
Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients
With Acute Hypoxemic Respiratory Failure Due to COVID-19.
JAMA. 2022;327:2022-2023.
PubMed: http://www.amedeo.com/p2.php?id=35608590&s=flu&pm=2
Share: http://m.amedeo.com/35608590
46. YARNELL CJ, Sklar MC.
Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients
With Acute Hypoxemic Respiratory Failure Due to COVID-19.
JAMA. 2022;327:2023.
PubMed: http://www.amedeo.com/p2.php?id=35608589&s=flu&pm=2
Share: http://m.amedeo.com/35608589
47. OSTER ME, Shay DK, Shimabukuro TT.
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
JAMA. 2022;327:2020-2021.
PubMed: http://www.amedeo.com/p2.php?id=35608588&s=flu&pm=2
Share: http://m.amedeo.com/35608588
48. COUPER K, Connolly BA, McAuley DF.
Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients
With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.
JAMA. 2022;327:2023-2024.
PubMed: http://www.amedeo.com/p2.php?id=35608586&s=flu&pm=2
Share: http://m.amedeo.com/35608586
49. KUEHN BM.
Cardiac Complications More Common After COVID-19 Than Vaccination.
JAMA. 2022;327:1951.
PubMed: http://www.amedeo.com/p2.php?id=35608572&s=flu&pm=2
Share: http://m.amedeo.com/35608572
50. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al.
Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal
Outcomes.
JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
PubMed: http://www.amedeo.com/p2.php?id=35499852&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35499852
51. TSAY SV, Bartoces M, Gouin K, Kabbani S, et al.
Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among
Medicare Beneficiaries, April 2020 to April 2021.
JAMA. 2022 Apr 8. pii: 2791077. doi: 10.1001/jama.2022.5471.
PubMed: http://www.amedeo.com/p2.php?id=35394497&s=flu&pm=2
Share: http://m.amedeo.com/35394497
52. BRADLEY MC, Perez-Vilar S, Chillarige Y, Dong D, et al.
Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April
2020 to August 2021.
JAMA. 2022 Apr 8. pii: 2791078. doi: 10.1001/jama.2022.4877.
PubMed: http://www.amedeo.com/p2.php?id=35394487&s=flu&pm=2
Share: http://m.amedeo.com/35394487
53. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al.
Where is the next SARS-CoV-2 variant of concern?
Lancet. 2022;399:1938-1939.
PubMed: http://www.amedeo.com/p2.php?id=35598619&s=flu&pm=2
Share: http://m.amedeo.com/35598619
54. HORTON R.
Offline: How to fix pandemic preparedness.
Lancet. 2022;399:1927.
PubMed: http://www.amedeo.com/p2.php?id=35598612&s=flu&pm=2
Share: http://m.amedeo.com/35598612
55. JHA P, Brown PE, Ansumana R.
Counting the global COVID-19 dead.
Lancet. 2022 May 6. pii: S0140-6736(22)00845.
PubMed: http://www.amedeo.com/p2.php?id=35533709&s=flu&pm=2
Share: http://m.amedeo.com/35533709
56. Remdesivir and three other drugs for hospitalised patients with COVID-19: final
results of the WHO Solidarity randomised trial and updated meta-analyses.
Lancet. 2022 May 2. pii: S0140-6736(22)00519.
PubMed: http://www.amedeo.com/p2.php?id=35512728&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35512728
57. HALL VG, Ferreira VH, Ku T, Ierullo M, et al.
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.
PubMed: http://www.amedeo.com/p2.php?id=34379917&s=flu&pm=2
Share: http://m.amedeo.com/34379917
58. HEKMATI A, Luhar M, Krishnamachari B, Mataric M, et al.
Simulating COVID-19 classroom transmission on a university campus.
Proc Natl Acad Sci U S A. 2022;119:e2116165119.
PubMed: http://www.amedeo.com/p2.php?id=35609196&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35609196
59. MUTSCH B, Heiber M, Gratz F, Hain R, et al.
Aerosol particle emission increases exponentially above moderate exercise
intensity resulting in superemission during maximal exercise.
Proc Natl Acad Sci U S A. 2022;119:e2202521119.
PubMed: http://www.amedeo.com/p2.php?id=35605123&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35605123
60. COMAR CE, Otter CJ, Pfannenstiel J, Doerger E, et al.
MERS-CoV endoribonuclease and accessory proteins jointly evade host innate
immunity during infection of lung and nasal epithelial cells.
Proc Natl Acad Sci U S A. 2022;119:e2123208119.
PubMed: http://www.amedeo.com/p2.php?id=35594398&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35594398
61. ELTOBGY MM, Zani A, Kenney AD, Estfanous S, et al.
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting
inflammation and immunothrombosis.
Proc Natl Acad Sci U S A. 2022;119:e2202012119.
PubMed: http://www.amedeo.com/p2.php?id=35588457&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35588457
62. HARRISON NL, Sachs JD.
A call for an independent inquiry into the origin of the SARS-CoV-2 virus.
Proc Natl Acad Sci U S A. 2022;119:e2202769119.
PubMed: http://www.amedeo.com/p2.php?id=35588448&s=flu&pm=2
Share: http://m.amedeo.com/35588448
63. FOO D, Sarna M, Pereira G, Moore HC, et al.
Maternal influenza vaccination and child mortality: Longitudinal,
population-based linked cohort study.
Vaccine. 2022 May 20. pii: S0264-410X(22)00614.
PubMed: http://www.amedeo.com/p2.php?id=35606236&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35606236
64. KITCHEN M, Leierer G, Kistner O, Wodal W, et al.
High seroprotection rates and geometric mean titre increases after repeated
annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Vaccine. 2022 May 20. pii: S0264-410X(22)00575.
PubMed: http://www.amedeo.com/p2.php?id=35606234&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35606234
65. MCELFISH PA, Selig JP, Scott AJ, Rowland B, et al.
Associations between 5-year influenza vaccination and sociodemographic factors
and healthcare access among Arkansans.
Vaccine. 2022 May 20. pii: S0264-410X(22)00615.
PubMed: http://www.amedeo.com/p2.php?id=35606233&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35606233
66. SALO-TUOMINEN K, Teros-Jaakkola T, Toivonen L, Ollila H, et al.
Parental socioeconomic and psychological determinants of the 2009 pandemic
influenza A(H1N1) vaccine uptake in children.
Vaccine. 2022 May 17. pii: S0264-410X(22)00582.
PubMed: http://www.amedeo.com/p2.php?id=35595660&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35595660
67. GASTEIGER N, Gasteiger C, Vedhara K, Broadbent E, et al.
Characteristics associated with the willingness to receive a COVID-19 vaccine and
an exploration of the general public’s perceptions: A mixed-methods approach.
Vaccine. 2022 May 5. pii: S0264-410X(22)00547.
PubMed: http://www.amedeo.com/p2.php?id=35562194&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35562194
68. BIFULCO M, Di Zazzo E, Pisanti S, Martini M, et al.
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory
vaccination: An Italian phenomenon?
Vaccine. 2022 May 6. pii: S0264-410X(22)00492.
PubMed: http://www.amedeo.com/p2.php?id=35534315&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35534315
69. BOTHUN LS, Feeder SE, Poland GA.
Readability of COVID-19 vaccine information for the general public.
Vaccine. 2022 May 3. pii: S0264-410X(22)00546.
PubMed: http://www.amedeo.com/p2.php?id=35534313&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35534313
70. LUMBRERAS ARETA M, Valiton A, Diana A, Morales M, et al.
Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19
pandemic: A multicentric, prospective, survey-based study.
Vaccine. 2022 May 6. pii: S0264-410X(22)00533.
PubMed: http://www.amedeo.com/p2.php?id=35534311&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35534311
71. HUSSAIN B, Latif A, Timmons S, Nkhoma K, et al.
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic
review of UK studies.
Vaccine. 2022 Apr 28. pii: S0264-410X(22)00446.
PubMed: http://www.amedeo.com/p2.php?id=35534309&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35534309
72. MEISTER TL, Gottsauner JM, Schmidt B, Heinen N, et al.
Mouthrinses against SARS-CoV-2 – High antiviral effectivity by membrane
disruption in vitro translates to mild effects in a randomized placebo-controlled
clinical trial.
Virus Res. 2022;316:198791.
PubMed: http://www.amedeo.com/p2.php?id=35504446&s=flu&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35504446
Share this:
Zika Virus References Library (by AMEDEO, May 22 ’22)
1. FONG YD, Chu JJH.
Natural products as Zika antivirals.
Med Res Rev. 2022 May 20. doi: 10.1002/med.21891.
PubMed: http://www.amedeo.com/p2.php?id=35593443&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35593443
2. GAUNT MW, Pettersson JH, Kuno G, Gaunt B, et al.
Widespread interspecific phylogenetic tree incongruence between mosquito-borne
and insect-specific flaviviruses at hotspots originally identified in Zika virus.
Virus Evol. 2022;8:veac027.
PubMed: http://www.amedeo.com/p2.php?id=35591877&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35591877
3. AISENBERG LK, Rousseau KE, Cascino K, Massaccesi G, et al.
Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses.
JCI Insight. 2022 May 19. pii: 151782. doi: 10.1172/jci.insight.151782.
PubMed: http://www.amedeo.com/p2.php?id=35588060&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35588060
4. LIU Y, Li K, Xu YP, Zhu Z, et al.
Characterization of m(6) A modifications in the contemporary Zika virus genome
and host cellular transcripts.
J Med Virol. 2022 May 19. doi: 10.1002/jmv.27869.
PubMed: http://www.amedeo.com/p2.php?id=35587571&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35587571
5. MCCARTHY EE, Odorizzi PM, Lutz E, Smullin CP, et al.
A cytotoxic-skewed immune set point predicts low neutralizing antibody levels
after Zika virus infection.
Cell Rep. 2022;39:110815.
PubMed: http://www.amedeo.com/p2.php?id=35584677&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35584677
6. ALVARADO-DOMENECH LI, Rivera-Amill V, Appleton AA, Rosario-Villafane V, et al.
Early childhood neurodevelopmental outcomes in children with prenatal Zika virus
exposure: a cohort study in Puerto Rico.
J Pediatr. 2022 May 13. pii: S0022-3476(22)00423.
PubMed: http://www.amedeo.com/p2.php?id=35577118&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35577118
7. CREISHER PS, Lei J, Sherer ML, Dziedzic A, et al.
Downregulation of transcriptional activity, increased inflammation, and damage in
the placenta following in utero Zika virus infection is associated with adverse
pregnancy outcomes.
Front Virol. 2022;2.
PubMed: http://www.amedeo.com/p2.php?id=35573818&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35573818
8. COSTA CBDC, Freitas D.
Ocular findings of congenital Zika virus infection with microcephaly.
Int Ophthalmol. 2022 May 15. pii: 10.1007/s10792-022-02311.
PubMed: http://www.amedeo.com/p2.php?id=35569052&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35569052
9. MALESKI ALA, Rosa JGS, Bernardo JTG, Astray RM, et al.
Recapitulation of Retinal Damage in Zebrafish Larvae Infected with Zika Virus.
Cells. 2022;11.
PubMed: http://www.amedeo.com/p2.php?id=35563763&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35563763
10. ATAEI A, Kabir MA, Lau AWC, Asghar W, et al.
Rheotaxis-based microfluidic device for selecting sperm from samples infected
with a virus.
F S Sci. 2021;2:376-382.
PubMed: http://www.amedeo.com/p2.php?id=35559860&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35559860
11. BUKHARI SNH, Webber J, Mehbodniya A.
Decision tree based ensemble machine learning model for the prediction of Zika
virus T-cell epitopes as potential vaccine candidates.
Sci Rep. 2022;12:7810.
PubMed: http://www.amedeo.com/p2.php?id=35552469&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35552469
12. KONAN KV, Ogbamikael SA, Yager E, Yamaji T, et al.
Modulation of Zika virus replication via glycosphingolipids.
Virology. 2022;572:17-27.
PubMed: http://www.amedeo.com/p2.php?id=35550476&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35550476
13. DA SILVA NETO SR, Tabosa de Oliveira T, Teixiera IV, Medeiros Neto L, et al.
Arboviral disease record data – Dengue and Chikungunya, Brazil, 2013-2020.
Sci Data. 2022;9:198.
PubMed: http://www.amedeo.com/p2.php?id=35538103&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35538103
14. YAN Y, Yang J, Xiao D, Yin J, et al.
Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus
infections by targeting envelope proteins.
Antiviral Res. 2022;202:105325.
PubMed: http://www.amedeo.com/p2.php?id=35460703&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35460703
15. CORREA DE OLIVEIRA PM, Barreto Sousa JP, Albernaz LC, Coelho-Ferreira M, et al.
Bioprospection for new larvicides against Aedes aegypti based on ethnoknowledge
from the Amazonian Sao Sebastiao de Marinau riverside community.
J Ethnopharmacol. 2022;293:115284.
PubMed: http://www.amedeo.com/p2.php?id=35447199&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35447199
16. DE OLIVEIRA LAGE M, Barbosa G, Andrade V, Gomes H, et al.
Ovipositional Reproduction of the Dengue Vector for Identifying High-Risk Urban
Areas.
Ecohealth. 2022;19:85-98.
PubMed: http://www.amedeo.com/p2.php?id=35441255&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35441255
17. GONZALEZ-SANTILLAN FJ, Contreras-Perera Y, Davila-Barboza JA, Juache-Villagrana AE, et al.
Fitness Cost of Sequential Selection with Deltamethrin in Aedes aegypti (Diptera:
Culicidae).
J Med Entomol. 2022;59:930-939.
PubMed: http://www.amedeo.com/p2.php?id=35389486&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35389486
18. GABRYELSKA MM, Badrock AP, Lau JY, O’Keefe RT, et al.
Global mapping of RNA homodimers in living cells.
Genome Res. 2022;32:956-967.
PubMed: http://www.amedeo.com/p2.php?id=35332098&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35332098
19. WNETRZAK A, Chachaj-Brekiesz A, Kus K, Lipiec E, et al.
Oxysterols can act antiviral through modification of lipid membrane properties –
The Langmuir monolayer study.
J Steroid Biochem Mol Biol. 2022;220:106092.
PubMed: http://www.amedeo.com/p2.php?id=35272016&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35272016
20. JABERHASHEMI SA, Azari-Hamidian S, Soltani A, Azizi K, et al.
The Fauna, Diversity, and Bionomics of Culicinae (Diptera: Culicidae) in
Hormozgan Province, Southern Iran.
J Med Entomol. 2022;59:987-996.
PubMed: http://www.amedeo.com/p2.php?id=35134206&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35134206
21. RAMPAZZO RCP, Zambenedetti MR, Alexandrino F, Jacomasso T, et al.
Development, verification, and validation of an RT-qPCR-based protocol for Yellow
Fever diagnosis.
Int J Infect Dis. 2022;119:34-37.
PubMed: http://www.amedeo.com/p2.php?id=34990800&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34990800
22. LOW ZY, Wen Yip AJ, Chow VTK, Lal SK, et al.
The Suppressor of Cytokine Signalling family of proteins and their potential
impact on COVID-19 disease progression.
Rev Med Virol. 2022;32:e2300.
PubMed: http://www.amedeo.com/p2.php?id=34546610&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34546610
23. TSUJI I, Vang F, Dominguez D, Karwal L, et al.
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to
Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
J Virol. 2022 May 16:e0007122. doi: 10.1128/jvi.00071.
PubMed: http://www.amedeo.com/p2.php?id=35575481&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35575481
Share this:
Zika Virus Research References (by AMEDEO, May 9 ’22)
1. LE BRAS A.
A NHP model of congenital Zika virus infection.
Lab Anim (NY). 2022;51:128.
PubMed: http://www.amedeo.com/p2.php?id=35505139&s=zik&pm=2
Share: http://m.amedeo.com/35505139
2. MOREIRA MCN, Mendes CHF, Nascimento MAFD, Melo APL, et al.
Stigmas of congenital Zika syndrome: family perspectives.
Cad Saude Publica. 2022;38:e00104221.
PubMed: http://www.amedeo.com/p2.php?id=35508028&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35508028
3. MARTELETO LJ, Sereno LGF, Coutinho RZ, Dondero M, et al.
Fertility trends during successive novel infectious disease outbreaks: Zika and
COVID-19 in Brazil.
Cad Saude Publica. 2022;38:EN230621.
PubMed: http://www.amedeo.com/p2.php?id=35508025&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35508025
4. VILLALOBOS-SANCHEZ E, Burciaga-Flores M, Zapata-Cuellar L, Camacho-Villegas TA, et al.
Possible Routes for Zika Virus Vertical Transmission in Human Placenta: A
Comprehensive Review.
Viral Immunol. 2022 May 3. doi: 10.1089/vim.2021.0199.
PubMed: http://www.amedeo.com/p2.php?id=35506896&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35506896
5. MARTELETO LJ, Dondero M.
Navigating women’s reproductive health and childbearing during public health
crises: Covid-19 and Zika in Brazil.
World Dev. 2021;139.
PubMed: http://www.amedeo.com/p2.php?id=35495087&s=zik&pm=2
Share: http://m.amedeo.com/35495087
6. MASK E, Hodara VL, Callery JE, Parodi LM, et al.
Molecular Approaches for the Validation of the Baboon as a Nonhuman Primate Model
for the Study of Zika Virus Infection.
Front Cell Infect Microbiol. 2022;12:880860.
PubMed: http://www.amedeo.com/p2.php?id=35493734&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35493734
7. REYNA-LARA A, Soriano-Panos D, Arias-Castro JH, Martinez HJ, et al.
A metapopulation approach to identify targets for Wolbachia-based dengue control.
Chaos. 2022;32:041105.
PubMed: http://www.amedeo.com/p2.php?id=35489839&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35489839
8. SALVESEN VON ESSEN B, D’Angelo DV, Shulman HB, Virella WH, et al.
Rapid Population-Based Surveillance of Prenatal and Postpartum Experiences During
Public Health Emergencies, Puerto Rico, 20162018.
Am J Public Health. 2022;112:574-578.
PubMed: http://www.amedeo.com/p2.php?id=35319933&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35319933
9. LAI SC, Huang YY, Wey JJ, Tsai MH, et al.
Development of Novel Dengue NS1 Multiplex Lateral Flow Immunoassay to
Differentiate Serotypes in Serum of Acute Phase Patients and Infected Mosquitoes.
Front Immunol. 2022;13:852452.
PubMed: http://www.amedeo.com/p2.php?id=35309328&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35309328
10. MUTRICY R, Matheus S, Mosnier E, Martinez-Lorenzi E, et al.
Mayaro virus infection in French Guiana, a cross sectional study 2003-2019.
Infect Genet Evol. 2022;99:105243.
PubMed: http://www.amedeo.com/p2.php?id=35151887&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35151887
11. SKALINSKI LM, Dalvi APR, Natividade M, Braga JU, et al.
The triple epidemics of arboviruses in Feira de Santana, Brazilian Northeast:
Epidemiological characteristics and diffusion patterns.
Epidemics. 2022;38:100541.
PubMed: http://www.amedeo.com/p2.php?id=35123281&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35123281
12. BALASUBRAMANIAN A, Chatterjee J.
Bioinformatics approach used in undergraduate research to predict siRNA as ZIKV
therapeutics.
Biochem Mol Biol Educ. 2022;50:237-245.
PubMed: http://www.amedeo.com/p2.php?id=35089641&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35089641
13. LIU Z, Wu J, Qin Z, Dong C, et al.
Endogenous cathelicidin is required for protection against ZIKV-caused testis
damage via inactivating virons.
Antiviral Res. 2022;198:105248.
PubMed: http://www.amedeo.com/p2.php?id=35038500&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35038500
14. LAYCOCK T, Urena Paniego C, Javier J.
The threat of mosquito-borne arboviral disease in Spain: A bibliographic review.
Med Clin (Barc). 2022;158:378-386.
PubMed: http://www.amedeo.com/p2.php?id=35027150&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35027150
15. NEGORO H, Chatziantonio C, Razzaque MS.
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for
viral insults: relevance to the COVID-19 crisis.
Expert Rev Anti Infect Ther. 2022;20:657-661.
PubMed: http://www.amedeo.com/p2.php?id=34927515&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34927515
16. AZZIZ-BAUMGARTNER E, Gonzalez R, Davis W, Calvo A, et al.
Lower cognitive scores among toddlers in birth cohorts with acute respiratory
illnesses, fevers, and laboratory-confirmed influenza.
Influenza Other Respir Viruses. 2022;16:101-112.
PubMed: http://www.amedeo.com/p2.php?id=34519426&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34519426
17. FAWZI MM, Sharmeen JB, Juliano H, Chaker EK, et al.
Endemic and Indigenous Plants from Mascarene Islands with Antiviral Propensities.
Curr Drug Targets. 2022;23:72-86.
PubMed: http://www.amedeo.com/p2.php?id=34431460&s=zik&pm=2
ABSTRACT available
Share: http://m.amedeo.com/34431460
18. RIEMERSMA KK, Jaeger AS, Crooks CM, Braun KM, et al.
Correction for Riemersma et al., “Rapid Evolution of Enhanced Zika Virus
Virulence during Direct Vertebrate Transmission Chains”.
J Virol. 2022 May 2:e0050122. doi: 10.1128/jvi.00501.
PubMed: http://www.amedeo.com/p2.php?id=35499321&s=zik&pm=2
Share: http://m.amedeo.com/35499321
Share this:
Coronavirus Disease Research References (by AMEDEO, May 9 ’22)
1. CHINAI B, Rajagopal R, Lee JJ, Jagpal S, et al.
The Development and Distribution of the COVID-19 Vaccine.
Am J Respir Crit Care Med. 2022;205:1112.
PubMed: http://www.amedeo.com/p2.php?id=35119971&s=cov&pm=2
Share: http://m.amedeo.com/35119971
2. KRYCHTIUK KA, Newby LK.
Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d
(4.2 events/100 000 persons).
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0021.
PubMed: http://www.amedeo.com/p2.php?id=35500266&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35500266
3. MOURAD O, Chagla Z.
In high-risk outpatients with COVID-19, remdesivir reduced COVID-19-related
hospitalization or all-cause death at 28 d.
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0026.
PubMed: http://www.amedeo.com/p2.php?id=35500263&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35500263
4. SINGH KP, Tong SYC.
In adults hospitalized with COVID-19, adding remdesivir to standard care did not
reduce in-hospital mortality.
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0025.
PubMed: http://www.amedeo.com/p2.php?id=35500262&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35500262
5. GRANWEHR BP.
In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at >/=7 d
after the second dose.
Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0028.
PubMed: http://www.amedeo.com/p2.php?id=35500261&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35500261
6. ZAHRADKA I, Petr V, Modos I, Magicova M, et al.
Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates
in Kidney Transplant Recipients : A Registry-Based Report.
Ann Intern Med. 2022 May 3. doi: 10.7326/M21-2973.
PubMed: http://www.amedeo.com/p2.php?id=35500256&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35500256
7. MAHASE E.
Covid-19: Remdesivir has “small effect” against death or progression to
ventilation, WHO trial finds.
BMJ. 2022;377:o1118.
PubMed: http://www.amedeo.com/p2.php?id=35508315&s=cov&pm=2
Share: http://m.amedeo.com/35508315
8. URNER M, Barnett AG, Bassi GL, Brodie D, et al.
Venovenous extracorporeal membrane oxygenation in patients with acute covid-19
associated respiratory failure: comparative effectiveness study.
BMJ. 2022;377:e068723.
PubMed: http://www.amedeo.com/p2.php?id=35508314&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35508314
9. TURABIAN JL.
An ostrich strategy for covid-19 is too risky.
BMJ. 2022;377:o1112.
PubMed: http://www.amedeo.com/p2.php?id=35504630&s=cov&pm=2
Share: http://m.amedeo.com/35504630
10. SHEPHERD A.
Covid-19: Campaign takes on Pfizer’s “profiteering”.
BMJ. 2022;377:o1111.
PubMed: http://www.amedeo.com/p2.php?id=35504624&s=cov&pm=2
Share: http://m.amedeo.com/35504624
11. KIM KW, Wang X, Adhikari A, Yeang M, et al.
Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after
onset of COVID-19 in a hospitalized patient with pneumonia.
J Med Virol. 2022 May 4. doi: 10.1002/jmv.27832.
PubMed: http://www.amedeo.com/p2.php?id=35509147&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35509147
12. KEIJSERS CJPW, Broeders MEAC, Baptista Lopes V, Klinkert AF, et al.
Memory impairment and concentration problems in COVID-19 survivors eight weeks
after non-ICU hospitalization: a retrospective cohort study.
J Med Virol. 2022 May 4. doi: 10.1002/jmv.27831.
PubMed: http://www.amedeo.com/p2.php?id=35509111&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35509111
13. ISLAM F, Dhawan M, Mitra S, Bin Emran T, et al.
Assessing the risks associated with the emergence of Florona and possible
preventive measures.
J Med Virol. 2022 May 4. doi: 10.1002/jmv.27830.
PubMed: http://www.amedeo.com/p2.php?id=35508914&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35508914
14. PEIXOTO SG, Wolf JM, Glaeser AB, Maccari JG, et al.
Longer length of stay, days between discharge/first readmission, and pulmonary
involvement >/=50% increase prevalence of admissions in ICU in unplanned
readmissions after COVID-19 hospitalizations.
J Med Virol. 2022 May 4. doi: 10.1002/jmv.27792.
PubMed: http://www.amedeo.com/p2.php?id=35506668&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35506668
15. WU F, Yuan Y, Deng Z, Yin D, et al.
Acceptance of COVID-19 Booster Vaccination Based on the Protection Motivation
Theory (PMT): A Cross-Sectional Study in China.
J Med Virol. 2022 May 4. doi: 10.1002/jmv.27825.
PubMed: http://www.amedeo.com/p2.php?id=35506329&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35506329
16. FONSECA MHG, Silva MFS, Pinto ACMD, Melo ACL, et al.
Persistently positive SARS-CoV-2 specific IgM during one-year follow-up.
J Med Virol. 2022 May 3. doi: 10.1002/jmv.27822.
PubMed: http://www.amedeo.com/p2.php?id=35505640&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35505640
17. SHAFIEE A, Aghajanian S, Athar MMT, Gargari OK, et al.
Epstein-Barr virus and COVID-19.
J Med Virol. 2022 May 3. doi: 10.1002/jmv.27823.
PubMed: http://www.amedeo.com/p2.php?id=35505635&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35505635
18. KHOKHER W, Beran A, Iftikhar S, Malhas SE, et al.
Pulse versus Non-pulse Steroid Regimens in Patients with Coronavirus Disease
2019: A Systematic Review and Meta-Analysis.
J Med Virol. 2022 May 3. doi: 10.1002/jmv.27824.
PubMed: http://www.amedeo.com/p2.php?id=35505469&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35505469
19. SEDIGHI M, Amanollahi A, Moghaddam OM, Ghafouri HB, et al.
Linear mixed model analysis to evaluate correlations between remdesivir adverse
effects with age and gender of patients with mild Covid-19 pneumonia.
J Med Virol. 2022 May 2. doi: 10.1002/jmv.27800.
PubMed: http://www.amedeo.com/p2.php?id=35491957&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35491957
20. BANERJEE S, Wang X, Du S, Zhu C, et al.
Comprehensive Role of SARS-CoV-2 Spike Glycoprotein in Regulating Host Signaling
Pathway.
J Med Virol. 2022 Apr 29. doi: 10.1002/jmv.27820.
PubMed: http://www.amedeo.com/p2.php?id=35488404&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35488404
21. KHAN YH, Mallhi TH, Alanazi AS, Butt MH, et al.
Outbreak of Acute Hepatitis of Unknown etiology in Children; The Critical Role of
Healthcare Professionals in Neutralizing Misleading Narratives during the
COVID-19 Pandemic.
J Med Virol. 2022 Apr 29. doi: 10.1002/jmv.27819.
PubMed: http://www.amedeo.com/p2.php?id=35488384&s=cov&pm=2
Share: http://m.amedeo.com/35488384
22. BESANCON L, Flahault A, Meyerowitz-Katz G.
Mobility during the pandemic: how did our movements shape the course of COVID-19?
J Travel Med. 2022 May 3. pii: 6577267. doi: 10.1093.
PubMed: http://www.amedeo.com/p2.php?id=35511717&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35511717
23. DONG S, Kong N, Zhang Y, Li Y, et al.
TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading
Viral Nucleocapsid Protein and Activating Type I Interferon Signaling.
J Virol. 2022 May 2:e0007022. doi: 10.1128/jvi.00070.
PubMed: http://www.amedeo.com/p2.php?id=35499322&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35499322
24. SLOMSKI A.
Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
JAMA. 2022;327:1641.
PubMed: http://www.amedeo.com/p2.php?id=35503358&s=cov&pm=2
Share: http://m.amedeo.com/35503358
25. MARKS P, Woodcock J, Califf R.
COVID-19 Vaccination-Becoming Part of the New Normal.
JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
PubMed: http://www.amedeo.com/p2.php?id=35499853&s=cov&pm=2
Share: http://m.amedeo.com/35499853
26. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al.
Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal
Outcomes.
JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
PubMed: http://www.amedeo.com/p2.php?id=35499852&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35499852
27. Remdesivir and three other drugs for hospitalised patients with COVID-19: final
results of the WHO Solidarity randomised trial and updated meta-analyses.
Lancet. 2022 May 2. pii: S0140-6736(22)00519.
PubMed: http://www.amedeo.com/p2.php?id=35512728&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35512728
28. ADEPOJU P.
Africa CDC warns COVID-19 vaccine production could cease.
Lancet. 2022;399:1683.
PubMed: http://www.amedeo.com/p2.php?id=35490681&s=cov&pm=2
Share: http://m.amedeo.com/35490681
29. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al.
Effects of early-life poverty on health and human capital in children and
adolescents: analyses of national surveys and birth cohort studies in LMICs.
Lancet. 2022;399:1741-1752.
PubMed: http://www.amedeo.com/p2.php?id=35489358&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35489358
30. BAKER JM, Buchfellner M, Britt W, Sanchez V, et al.
Acute Hepatitis and Adenovirus Infection Among Children – Alabama, October
2021-February 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:638-640.
PubMed: http://www.amedeo.com/p2.php?id=35511732&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35511732
31. PRASAD N, Derado G, Nanduri SA, Reses HE, et al.
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in
Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread
Circulation of the Omicron Variant – United States, February 14-March 27, 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:633-637.
PubMed: http://www.amedeo.com/p2.php?id=35511708&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35511708
32. PERSAD G, Pandya A.
A Comprehensive Covid-19 Response – The Need for Economic Evaluation.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMp2202828.
PubMed: http://www.amedeo.com/p2.php?id=35507511&s=cov&pm=2
Share: http://m.amedeo.com/35507511
33. HAGER KJ, Perez Marc G, Gobeil P, Diaz RS, et al.
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2201300.
PubMed: http://www.amedeo.com/p2.php?id=35507508&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35507508
34. RUBIN EJ, Baden LR, Morrissey S.
Audio Interview: Do We Need New Covid-19 Vaccines?
N Engl J Med. 2022;386:e52.
PubMed: http://www.amedeo.com/p2.php?id=35507489&s=cov&pm=2
Share: http://m.amedeo.com/35507489
35. ESTCOURT L, Callum J.
Convalescent Plasma for Covid-19 – Making Sense of the Inconsistencies.
N Engl J Med. 2022;386:1753-1754.
PubMed: http://www.amedeo.com/p2.php?id=35507487&s=cov&pm=2
Share: http://m.amedeo.com/35507487
36. DAI L, Gao L, Tao L, Hadinegoro SR, et al.
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults.
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMoa2202261.
PubMed: http://www.amedeo.com/p2.php?id=35507481&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35507481
37. NOHYNEK H, Wilder-Smith A.
Does the World Still Need New Covid-19 Vaccines?
N Engl J Med. 2022 May 4. doi: 10.1056/NEJMe2204695.
PubMed: http://www.amedeo.com/p2.php?id=35507476&s=cov&pm=2
Share: http://m.amedeo.com/35507476
38. MADHUSOODANAN J.
Health data for all.
Nature. 2022;605:182-183.
PubMed: http://www.amedeo.com/p2.php?id=35505184&s=cov&pm=2
Share: http://m.amedeo.com/35505184
39. KOZLOV M.
Risky ‘gain-of-function’ studies need stricter guidance, say US researchers.
Nature. 2022 May 3. pii: 10.1038/d41586-022-01209.
PubMed: http://www.amedeo.com/p2.php?id=35505104&s=cov&pm=2
Share: http://m.amedeo.com/35505104
40. Some people with COVID shed nearly 60 times as much virus as others.
Nature. 2022 May 4. pii: 10.1038/d41586-022-01224.
PubMed: http://www.amedeo.com/p2.php?id=35508733&s=cov&pm=2
Share: http://m.amedeo.com/35508733
41. MCCOSKER L.
How I found a way to balance research integrity with people’s welfare.
Nature. 2022 May 4. pii: 10.1038/d41586-022-01236.
PubMed: http://www.amedeo.com/p2.php?id=35508724&s=cov&pm=2
Share: http://m.amedeo.com/35508724
42. BAKER N, Phillips N.
Coronapod: COVID and diabetes, what the science says.
Nature. 2022 Apr 29. pii: 10.1038/d41586-022-01220.
PubMed: http://www.amedeo.com/p2.php?id=35488062&s=cov&pm=2
Share: http://m.amedeo.com/35488062
43. KOZLOV M.
Four lessons from the pandemic to reboot the NIH.
Nature. 2022;605:22-24.
PubMed: http://www.amedeo.com/p2.php?id=35449301&s=cov&pm=2
Share: http://m.amedeo.com/35449301
44. FRONZA M, Thavendiranathan P, Karur GR, Abdel-Qadir H, et al.
Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine-associated Myocarditis.
Radiology. 2022 May 3:220802. doi: 10.1148/radiol.220802.
PubMed: http://www.amedeo.com/p2.php?id=35503017&s=cov&pm=2
Share: http://m.amedeo.com/35503017
45. KOW CS, Ramachandram DS, Hasan SS.
Can COVID-19 vaccines improve cardiovascular outcomes?
Travel Med Infect Dis. 2022 Apr 29:102350. doi: 10.1016/j.tmaid.2022.102350.
PubMed: http://www.amedeo.com/p2.php?id=35500844&s=cov&pm=2
ABSTRACT available
Share: http://m.amedeo.com/35500844
Share this:
#Coronavirus #Research #References (May 10 ’21)
| What’s New on Coronavirus Topic at PubMed |
|---|
| Tracing genetic signatures of bat-to-human coronaviruses and early transmission of North American SARS-CoV-2. Ou X, Yang Z, Zhu D, Mao S, Wang M, Jia R, Chen S, Liu M, Yang Q, Wu Y, Zhao X, Zhang S, Huang J, Gao Q, Liu Y, Zhang L, Peopplenbosch M, Pan Q, Cheng A. Transbound Emerg Dis. 2021 May 9. doi: 10.1111/tbed.14148. Online ahead of print. PMID: 33966351 |
| Imaging approach to COVID-19 Associated Pulmonary Embolism. Trunz LM, Lee P, Lange SM, Pomeranz CL, Needleman L, Ford RW, Karambelkar A, Sundaram B. Int J Clin Pract. 2021 May 9:e14340. doi: 10.1111/ijcp.14340. Online ahead of print. PMID: 33966326 |
| Geographical distribution and prevalence of mental disorders among healthcare workers in China: A cross-sectional country-wide survey: A cross-sectional study to assess mental disorders of healthcare workers in China. Yang X, Chen D, Chen Y, Wang N, Lyv C, Li Y, Jie J, Zhou T, Li Y, Zhou P. Int J Health Plann Manage. 2021 May 8. doi: 10.1002/hpm.3186. Online ahead of print. PMID: 33966289 |
| Long COVID-19: an emerging pandemic in itself. Iyengar KP, Jain VK, Vaishya R, Ish P. Adv Respir Med. 2021;89(2):234-236. doi: 10.5603/ARM.a2021.0040. PMID: 33966266 No abstract available. |
| Antifibrotics for COVID-19 related lung fibrosis: Agents with benefits? Mishra M, Sindhwani G. Adv Respir Med. 2021;89(2):231-233. doi: 10.5603/ARM.a2021.0023. PMID: 33966265 |
| Coronavirus disease 2019 (COVID-19): a brief overview of features and current treatment. Al-Iede M, Badran E, Al-Lawama M, Daher A, Al-Zayadneh E, Aleidi SM, Khawaldeh T, Alqutawneh B. Adv Respir Med. 2021;89(2):158-172. doi: 10.5603/ARM.a2021.0041. PMID: 33966263 |
| Predictors of mortality in patients with severe COVID-19 pneumonia – a retrospective study. Mahendra M, Nuchin A, Kumar R, Shreedhar S, Mahesh PA. Adv Respir Med. 2021;89(2):135-144. doi: 10.5603/ARM.a2021.0036. PMID: 33966261 |
| A clinical profile and factors associated with severity of the disease among Polish patients hospitalized due to COVID-19 – an observational study. Stachura T, Celejewska-Wójcik N, Polok K, Górka K, Lichołai S, Wójcik K, Krawczyk J, Kozłowska A, Przybyszowski M, Włoch T, Górka J, Sładek K. Adv Respir Med. 2021;89(2):124-134. doi: 10.5603/ARM.a2021.0035. PMID: 33966260 |
| The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study. So M, Steiger DJ, Takahashi M, Egorova NN, Kuno T. J Thromb Thrombolysis. 2021 May 8. doi: 10.1007/s11239-021-02477-5. Online ahead of print. PMID: 33966157 |
| Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis. Kwee RM, Adams HJA, Kwee TC. Eur Radiol. 2021 May 9. doi: 10.1007/s00330-021-08003-8. Online ahead of print. PMID: 33966132 |
| A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection. Ruan Y, Ryder REJ, De P, Field BCT, Narendran P, Iqbal A, Gandhi R, Harris S, Nagi D, Aziz U, Karra E, Ghosh S, Hanif W, Edwards AE, Zafar M, Dashora U, Várnai KA, Davies J, Wild SH, Wilmot EG, Webb D, Khunti K, Rea R; ABCD Covid-19 audit group. Diabetologia. 2021 May 8. doi: 10.1007/s00125-021-05463-x. Online ahead of print. PMID: 33966090 |
| Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights. Schober ME, Pavia AT, Bohnsack JF. Pediatr Crit Care Med. 2021 May 7. doi: 10.1097/PCC.0000000000002774. Online ahead of print. PMID: 33965992 |
| Coronavirus Disease 2019-Associated PICU Admissions: A Report From the Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study Registry. Tripathi S, Gist KM, Bjornstad EC, Kashyap R, Boman K, Chiotos K, Gharpure VP, Dapul H, Sayed IA, Kuehne J, Heneghan JA, Gupta M, Khandhar PB, Menon S, Gupta N, Kumar VK, Retford L, Zimmerman J, Bhalala US; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Pediatr Crit Care Med. 2021 May 10. doi: 10.1097/PCC.0000000000002760. Online ahead of print. PMID: 33965987 |
| COVID-19 crisis and minimally invasive surgery: a narrative review on intraoperative aerosol viral transmission and their impact on guidelines and clinical practice in Austria. Mun DH, Pradere B, Shariat SF, Yurdakul O, Remzi M. Curr Opin Urol. 2021 May 6. doi: 10.1097/MOU.0000000000000891. Online ahead of print. PMID: 33965981 |
| Hidden in plain sight: the (other) danger of COVID-19. Pikkel YY, Duek OS, Ben Naftali Y, Link Y, Khayr M, Ullmann Y. Melanoma Res. 2021 May 6. doi: 10.1097/CMR.0000000000000745. Online ahead of print. PMID: 33965975 |
| Viral Replication and Antibody Kinetics in the Recognition of Asymptomatic COVID-19 Patients. Pecho-Silva S, Navarro-Solsol AC, Panduro-Correa V, Rabaan AA, Maguiña JL, Rodriguez-Morales AJ, Arteaga-Livias K. Chemotherapy. 2021 May 7:1-5. doi: 10.1159/000515748. Online ahead of print. PMID: 33965937 Review. |
| Health Pandemic and Social Media: A Content Analysis of COVID-Related Posts on a Telegram Channel With More Than One Million Subscribers. Mehdipour S, Jannati N, Negarestani M, Amirzadeh S, Keshvardoost S, Zolala F, Vaezipour A, Hosseinnejad M, Fatehi F. Stud Health Technol Inform. 2021 May 7;279:122-129. doi: 10.3233/SHTI210098. PMID: 33965928 |
| FBSED based automatic diagnosis of COVID-19 using X-ray and CT images. Chaudhary PK, Pachori RB. Comput Biol Med. 2021 May 2;134:104454. doi: 10.1016/j.compbiomed.2021.104454. Online ahead of print. PMID: 33965836 |
| Vaccine hesitancy in the era of COVID-19. Troiano G, Nardi A. Public Health. 2021 Mar 4;194:245-251. doi: 10.1016/j.puhe.2021.02.025. Online ahead of print. PMID: 33965796 Review. |
| Mitigation policies, community mobility, and COVID-19 case counts in Australia, Japan, Hong Kong, and Singapore. Hakim AJ, Victory KR, Chevinsky JR, Hast MA, Weikum D, Kazazian L, Mirza S, Bhatkoti R, Schmitz MM, Lynch M, Marston BJ. Public Health. 2021 Feb 12;194:238-244. doi: 10.1016/j.puhe.2021.02.001. Online ahead of print. PMID: 33965795 |
| How is the COVID-19 pandemic affecting individuals with obsessive-compulsive disorder (OCD) symptoms? Wheaton MG, Ward HE, Silber A, McIngvale E, Björgvinsson T. J Anxiety Disord. 2021 Apr 30;81:102410. doi: 10.1016/j.janxdis.2021.102410. Online ahead of print. PMID: 33965747 |
| Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. Dugas M, Grote-Westrick T, Merle U, Fontenay M, Kremer AE, Hanses F, Vollenberg R, Lorentzen E, Tiwari-Heckler S, Duchemin J, Ellouze S, Vetter M, Fürst J, Schuster P, Brix T, Denkinger CM, Müller-Tidow C, Schmidt H, Tepasse PR, Kühn J. J Clin Virol. 2021 Apr 24;139:104847. doi: 10.1016/j.jcv.2021.104847. Online ahead of print. PMID: 33965698 |
| Intestinal expression of ACE2 in mice with high-fat diet-induced obesity and neonates exposed to maternal high-fat diet. Sun J, Chen L, Xiao XA, Jia MQ, Wang XY, Jiao H, Gao Y. Nutrition. 2021 Mar 7;90:111226. doi: 10.1016/j.nut.2021.111226. Online ahead of print. PMID: 33965680 |
| Impact of COVID-19 on the outreach strategy of cancer social service agencies in Singapore: A pre-post analysis with Facebook data. Ethan Tan K, Sesagiri Raamkumar A, Lin Wee H. J Biomed Inform. 2021 May 6:103798. doi: 10.1016/j.jbi.2021.103798. Online ahead of print. PMID: 33965641 |
| Convalescent Plasma Therapy in the management of COVID-19 Patients- The newer dimensions. Mahapatra S, Rattan R, Mohanty C. Transfus Clin Biol. 2021 May 6:S1246-7820(21)00070-7. doi: 10.1016/j.tracli.2021.04.009. Online ahead of print. PMID: 33965621 |
| Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Zhang X, Jiang M, Yang J. Int J Infect Dis. 2021 May 6:S1201-9712(21)00402-1. doi: 10.1016/j.ijid.2021.05.001. Online ahead of print. PMID: 33965598 |
| Impact of personal protective equipment use on health care workers’ physical health during the COVID-19 pandemic: a systematic review and meta-analysis. Galanis P, Vraka I, Fragkou D, Bilali A, Kaitelidou D. Am J Infect Control. 2021 May 6:S0196-6553(21)00296-0. doi: 10.1016/j.ajic.2021.04.084. Online ahead of print. PMID: 33965463 Review. |
| Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy. Sansone E, Tiraboschi M, Sala E, Albini E, Lombardo M, Castelli F, De Palma G. J Infect. 2021 May 6:S0163-4453(21)00225-5. doi: 10.1016/j.jinf.2021.04.038. Online ahead of print. PMID: 33965428 |
| The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. Carlos AJ, Ha DP, Yeh DW, Van Krieken R, Tseng CC, Zhang P, Gill P, Machida K, Lee AS. J Biol Chem. 2021 May 6:100759. doi: 10.1016/j.jbc.2021.100759. Online ahead of print. PMID: 33965375 |
| Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019. Yamaya T, Hagiwara E, Baba T, Kitayama T, Murohashi K, Higa K, Sato Y, Otoshi R, Tabata E, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Komatsu S, Ogura T. Respir Investig. 2021 Apr 27:S2212-5345(21)00071-X. doi: 10.1016/j.resinv.2021.04.002. Online ahead of print. PMID: 33965361 |
| Personal protective equipment preparedness in intensive care units during the coronavirus disease 2019 pandemic: An Asia-Pacific follow-up survey. Gullapalli N, Lim ZJ, Ramanathan K, Bihari S, Haji J, Shekar K, Wong WT, Rajamani A, Subramaniam A. Aust Crit Care. 2021 Mar 10:S1036-7314(21)00031-X. doi: 10.1016/j.aucc.2021.02.007. Online ahead of print. PMID: 33965312 |
| An unusual cause of spontaneous pneumothorax: Post-COVID-19 pulmonary fibrosis. Ufuk F, Yavas HG, Kis A. Am J Emerg Med. 2021 May 1:S0735-6757(21)00371-5. doi: 10.1016/j.ajem.2021.04.084. Online ahead of print. PMID: 33965276 |
| COVID-19 and violence against children: A review of early studies. Cappa C, Jijon I. Child Abuse Negl. 2021 Apr 14:105053. doi: 10.1016/j.chiabu.2021.105053. Online ahead of print. PMID: 33965215 |
| Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019. Mombrun M, Valette X. Chest. 2021 May;159(5):2115-2116. doi: 10.1016/j.chest.2020.11.069. PMID: 33965141 No abstract available. |
| Remarks About Retrospective Analysis of Ivermectin Effectiveness on Coronavirus Disease 2019 (ICON Study). Ortega-Guillén E, Meneses G, Coila E. Chest. 2021 May;159(5):2110-2111. doi: 10.1016/j.chest.2020.10.088. PMID: 33965137 No abstract available. |
| Should Vascular Abnormalities Be Integrated Into the Chest CT Imaging Signature of Coronavirus Disease 2019? Rotzinger DC, Qanadli SD. Chest. 2021 May;159(5):2107-2108. doi: 10.1016/j.chest.2020.12.049. PMID: 33965133 No abstract available. |
| Inhibition effects of eight anti-coronavirus drugs on glycosides metabolism and glycosidases in human gut microflora. Dai T, Wang M, Wang P, Dai L, Dai R, Meng Q. Pharmazie. 2021 May 1;76(5):195-201. doi: 10.1691/ph.2021.01005. PMID: 33964992 |
| Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012-2020. Zhang AR, Shi WQ, Liu K, Li XL, Liu MJ, Zhang WH, Zhao GP, Chen JJ, Zhang XA, Miao D, Ma W, Liu W, Yang Y, Fang LQ. Infect Dis Poverty. 2021 May 8;10(1):66. doi: 10.1186/s40249-021-00853-0. PMID: 33964965 |
| Temporal dynamic in the impact of COVID- 19 outbreak on cause-specific mortality in Guangzhou, China. Li L, Hang D, Dong H, Yuan-Yuan C, Bo-Heng L, Ze-Lin Y, Zhou Y, Chun-Quan O, Peng-Zhe Q. BMC Public Health. 2021 May 8;21(1):883. doi: 10.1186/s12889-021-10771-3. PMID: 33964914 |
Share this:
#Coronavirus #Research #Articles #References (April 16 ’21)
| What’s New on Coronavirus Topic on PubMed |
|---|
| Effect of Inadequate Sleep on Clinician Performance. Saadat H. Anesth Analg. 2021 May 1;132(5):1338-1343. doi: 10.1213/ANE.0000000000005369. PMID: 33857976 |
| Lessons Learned From the Rapid Expansion of Intensive Care Unit Care to the Operating Room During the Coronavirus Disease 2019 Pandemic. Meleties A, Morikawa N, Tanaka CY, Choice C, Berger J. Anesth Analg. 2021 May 1;132(5):1179-1181. doi: 10.1213/ANE.0000000000005497. PMID: 33857958 No abstract available. |
| Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia. Peerapornratana S, Sirivongrangson P, Tungsanga S, Tiankanon K, Kulvichit W, Putcharoen O, Kellum JA, Srisawat N. Blood Purif. 2021 Apr 15:1-8. doi: 10.1159/000515628. Online ahead of print. PMID: 33857940 |
| Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature. Khatri A, Chang KM, Berlinrut I, Wallach F. J Mycol Med. 2021 Apr 2;31(2):101125. doi: 10.1016/j.mycmed.2021.101125. Online ahead of print. PMID: 33857916 |
| Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia. Al Jumah M, Abulaban A, Aggad H, Al Bunyan R, AlKhawajah M, Al Malik Y, Almejally M, Alnajashi H, Alshamrani F, Bohlega S, Cupler EJ, ElBoghdady A, Makkawi S, Qureshi S, Shami S. Mult Scler Relat Disord. 2021 Mar 25;51:102925. doi: 10.1016/j.msard.2021.102925. Online ahead of print. PMID: 33857897 Review. |
| The performance of phenomenological models in providing near-term Canadian case projections in the midst of the COVID-19 pandemic: March – April, 2020. Smith BA, Bancej C, Fazil A, Mullah M, Yan P, Zhang S. Epidemics. 2021 Mar 19;35:100457. doi: 10.1016/j.epidem.2021.100457. Online ahead of print. PMID: 33857889 |
| Provocative thoughts from COVID-19: physician-centric solutions to physician burnout. Wang SS, Weaver JS, Revels JW. Clin Imaging. 2021 Mar 23;78:184-186. doi: 10.1016/j.clinimag.2021.03.016. Online ahead of print. PMID: 33857833 No abstract available. |
| Contamination-related behaviors, obsessions, and compulsions during the COVID-19 pandemic in a United States population sample. Samuels J, Holingue C, Nestadt PS, Bienvenu OJ, Phan P, Nestadt G. J Psychiatr Res. 2021 Apr 1;138:155-162. doi: 10.1016/j.jpsychires.2021.03.064. Online ahead of print. PMID: 33857786 |
| Does the SARS-CoV-2 pandemic really increase the frequency of peripheral facial palsy? Mutlu A, Kalcioglu MT, Gunduz AY, Bakici B, Yilmaz U, Cag Y. Am J Otolaryngol. 2021 Apr 7;42(5):103032. doi: 10.1016/j.amjoto.2021.103032. Online ahead of print. PMID: 33857779 |
| Development of flexible electrochemical impedance spectroscopy-based biosensing platform for rapid screening of SARS-CoV-2 inhibitors. Kiew LV, Chang CY, Huang SY, Wang PW, Heh CH, Liu CT, Cheng CH, Lu YX, Chen YC, Huang YX, Chang SY, Tsai HY, Kung YA, Huang PN, Hsu MH, Leo BF, Foo YY, Su CH, Hsu KC, Huang PH, Ng CJ, Kamarulzaman A, Yuan CJ, Shieh DB, Shih SR, Chung LY, Chang CC. Biosens Bioelectron. 2021 Apr 3;183:113213. doi: 10.1016/j.bios.2021.113213. Online ahead of print. PMID: 33857754 |
| Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections. Saqrane S, El Mhammedi MA, Lahrich S, Laghrib F, El Bouabi Y, Farahi A, Bakasse M. J Infect Public Health. 2021 Feb 20;14(5):655-660. doi: 10.1016/j.jiph.2021.02.006. Online ahead of print. PMID: 33857725 Review. |
| Dual catastrophe of COVID-19: Massive pulmonary embolism and stroke in a previously healthy young patient: A case report. AlSheef M, Zaidi ARZ, Abonab M, Obaid M, Bawazir K, Zaidi SZA, Kullab GJ, Alawfi S, Enani M. J Infect Public Health. 2021 Jan 30;14(5):647-650. doi: 10.1016/j.jiph.2021.01.009. Online ahead of print. PMID: 33857723 |
| COVID-19 and cancer: Sailing through the tides. Mohanty A, Agnihotri S, Mehta A, Rawal S. Pathol Res Pract. 2021 Mar 26;221:153417. doi: 10.1016/j.prp.2021.153417. Online ahead of print. PMID: 33857716 Review. |
| Potential Mechanisms of Anaphylaxis to COVID-19 mRNA Vaccines. Risma KA, Edwards KM, Hummell DS, Little FF, Norton AE, Stallings A, Wood RA, Milner J. J Allergy Clin Immunol. 2021 Apr 12:S0091-6749(21)00565-0. doi: 10.1016/j.jaci.2021.04.002. Online ahead of print. PMID: 33857566 |
| Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers. Padoan A, Dall’Olmo L, Della Rocca F, Barbaro F, Cosma C, Basso D, Cattelan A, Cianci V, Plebani M. Clin Chim Acta. 2021 Apr 12:S0009-8981(21)00129-7. doi: 10.1016/j.cca.2021.04.006. Online ahead of print. PMID: 33857476 |
| SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization. Hoffmann M, Zhang L, Krüger N, Graichen L, Kleine-Weber H, Hofmann-Winkler H, Kempf A, Nessler S, Riggert J, Winkler MS, Schulz S, Jäck HM, Pöhlmann S. Cell Rep. 2021 Apr 3:109017. doi: 10.1016/j.celrep.2021.109017. Online ahead of print. PMID: 33857422 |
| TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2. Kaushik D, Bhandari R, Kuhad A. Expert Opin Ther Targets. 2021 Apr 15. doi: 10.1080/14728222.2021.1918103. Online ahead of print. PMID: 33857397 |
| Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS-CoV-2. Shaheen A. Bioessays. 2021 Apr 15:e2000312. doi: 10.1002/bies.202000312. Online ahead of print. PMID: 33857328 |
| Viral sequencing reveals US healthcare personnel rarely become infected with SARS-CoV-2 through patient contact. Braun KM, Moreno GK, Buys A, Somsen ED, Bobholz M, Accola MA, Anderson L, Rehrauer WM, Baker DA, Safdar N, Lepak AJ, O’Connor DH, Friedrich TC. Clin Infect Dis. 2021 Apr 15:ciab281. doi: 10.1093/cid/ciab281. Online ahead of print. PMID: 33857303 |
| Leveraging mobile phone surveys during the COVID-19 pandemic in Ecuador and Sri Lanka: Methods, timeline and findings. Phadnis R, Wickramasinghe C, Zevallos JC, Davlin S, Kumarapeli V, Lea V, Lee J, Perera U, Solórzano FX, Vásconez JF. PLoS One. 2021 Apr 15;16(4):e0250171. doi: 10.1371/journal.pone.0250171. eCollection 2021. PMID: 33857226 |
| I-FABP is decreased in COVID-19 patients, independently of the prognosis. Guedj K, Uzzan M, Soudan D, Trichet C, Nicoletti A, Weiss E, Manceau H, Nuzzo A, Corcos O, Treton X, Peoc’h K. PLoS One. 2021 Apr 15;16(4):e0249799. doi: 10.1371/journal.pone.0249799. eCollection 2021. PMID: 33857216 |
| A qualitative study of the first batch of medical assistance team’s first-hand experience in supporting the nursing homes in Wuhan against COVID-19. Yang XF, Li MQ, Liao LL, Feng H, Zhao S, Wu S, Yin P. PLoS One. 2021 Apr 15;16(4):e0249656. doi: 10.1371/journal.pone.0249656. eCollection 2021. PMID: 33857214 |
| Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020. McGovern OL, Stenger M, Oliver SE, Anderson TC, Isenhour C, Mauldin MR, Williams N, Griggs E, Bogere T, Edens C, Curns AT, Lively JY, Zhou Y, Xu S, Diaz MH, Waller JL, Clarke KR, Evans ME, Hesse EM, Morris SB, McClung RP, Cooley LA, Logan N, Boyd AT, Taylor AW, Bajema KL, Lindstrom S, Elkins CA, Jones C, Hall AJ, Graitcer S, Oster AM, Fry AM, Fischer M, Conklin L, Gokhale RH. PLoS One. 2021 Apr 15;16(4):e0249901. doi: 10.1371/journal.pone.0249901. eCollection 2021. PMID: 33857209 |
| Factors Associated with Participation in Elementary School-Based SARS-CoV-2 Testing – Salt Lake County, Utah, December 2020-January 2021. Lewis NM, Hershow RB, Chu VT, Wu K, Milne AT, LaCross N, Hill M, Risk I, Hersh AL, Kirking HL, Tate JE, Vallabhaneni S, Dunn AC. MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):557-559. doi: 10.15585/mmwr.mm7015e1. PMID: 33857064 |
| Psychological Stress and Fear in Salaried Class Due to Coronavirus: Analysis of Facebook Posts. Bhatia S, Malhotra J. Psychiatr Danub. 2021 Spring;33(1):126-127. PMID: 33857060 No abstract available. |
| The Correlation between Psychiatric Disorders and COVID-19: A Narrative Review. He Y, Yu R, Ren J. Psychiatr Danub. 2021 Spring;33(1):76-85. doi: 10.24869/psyd.2021.76. PMID: 33857050 |
| Patterns of Media Use, Strength of Belief in COVID-19 Conspiracy Theories, and the Prevention of COVID-19 from March to July 2020 in the US. Romer D, Jamieson KH. J Med Internet Res. 2021 Apr 8. doi: 10.2196/25215. Online ahead of print. PMID: 33857008 |
| Bilateral Acute Anterior Uveitis and Corneal Punctate Epitheliopathy in Children Diagnosed with Multisystem Inflammatory Syndrome Secondary to COVID-19. Öztürk C, Yüce Sezen A, Savaş Şen Z, Özdem S. Ocul Immunol Inflamm. 2021 Apr 15:1-5. doi: 10.1080/09273948.2021.1909070. Online ahead of print. PMID: 33856952 |
| COVID-19 and Cardiovascular Disease: From Bench to Bedside. Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV 3rd, Kwon DH, Singh T, Tilton JC, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. Circ Res. 2021 Apr 16;128(8):1214-1236. doi: 10.1161/CIRCRESAHA.121.317997. Epub 2021 Apr 15. PMID: 33856918 |
| SARS-CoV-2 Infection Among Correctional Staff in the Federal Bureau of Prisons. Toblin RL, Cohen SI, Hagan LM. Am J Public Health. 2021 Apr 15:e1-e4. doi: 10.2105/AJPH.2021.306237. Online ahead of print. PMID: 33856883 |
| Comparing the initial impact of COVID-19 on burden and psychological distress among family caregivers of children with and without developmental disabilities. Chafouleas SM, Iovino EA. Sch Psychol. 2021 Apr 15. doi: 10.1037/spq0000426. Online ahead of print. PMID: 33856853 |
| Identification and Characterization of Species-Specific Severe Acute Respiratory Syndrome Coronavirus 2 Physicochemical Properties. Yerukala Sathipati S, Ho SY. J Proteome Res. 2021 Apr 15. doi: 10.1021/acs.jproteome.1c00156. Online ahead of print. PMID: 33856796 |
| Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank. Topless RK, Phipps-Green A, Leask M, Dalbeth N, Stamp LK, Robinson PC, Merriman TR. ACR Open Rheumatol. 2021 Apr 15. doi: 10.1002/acr2.11252. Online ahead of print. PMID: 33856739 |
| Association between environmental factors and COVID-19 in Shanghai, China. Ma Y, Cheng B, Shen J, Wang H, Feng F, Zhang Y, Jiao H. Environ Sci Pollut Res Int. 2021 Apr 15. doi: 10.1007/s11356-021-13834-5. Online ahead of print. PMID: 33856634 |
| A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy. Kantsadi AL, Cattermole E, Matsoukas MT, Spyroulias GA, Vakonakis I. J Biomol NMR. 2021 Apr 15. doi: 10.1007/s10858-021-00365-x. Online ahead of print. PMID: 33856612 |
| Coping and Mental Health in Early Adolescence during COVID-19. Hussong AM, Midgette AJ, Thomas TE, Coffman JL, Cho S. Res Child Adolesc Psychopathol. 2021 Apr 15. doi: 10.1007/s10802-021-00821-0. Online ahead of print. PMID: 33856611 |
| Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B, Chowdhury P, Goswami N, Gogoi N, Naiya T, Chetia P, Mahanta S, Chetia D, Tanti B, Borah P, Handique PJ. Mol Divers. 2021 Apr 15. doi: 10.1007/s11030-021-10211-9. Online ahead of print. PMID: 33856591 |
| Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases. Alzahrani ZA, Alghamdi KA, Almaqati AS. Rheumatol Int. 2021 Apr 15. doi: 10.1007/s00296-021-04857-9. Online ahead of print. PMID: 33856543 |
| Strategies to optimize a pediatric magnetic resonance imaging service. Xu L, Herrington J, Cahill K, Risacher S, Gee MS. Pediatr Radiol. 2021 Apr 15. doi: 10.1007/s00247-021-05059-y. Online ahead of print. PMID: 33856504 Review. |
| The Psychological Impact of COVID-19 on Hospital Staff. Hassamal S, Dong F, Hassamal S, Lee C, Ogunyemi D, Neeki MM. West J Emerg Med. 2021 Feb 8;22(2):346-352. doi: 10.5811/westjem.2020.11.49015. PMID: 33856322 |
| Clinical Features of Emergency Department Patients from Early COVID-19 Pandemic that Predict SARS-CoV-2 Infection: Machine-learning Approach. Chou EH, Wang CH, Hsieh YL, Namazi B, Wolfshohl J, Bhakta T, Tsai CL, Lien WC, Sankaranarayanan G, Lee CC, Lu TC. West J Emerg Med. 2021 Mar 4;22(2):244-251. doi: 10.5811/westjem.2020.12.49370. PMID: 33856307 |
| Who Stayed Home Under Safer-at-Home? Impacts of COVID-19 on Volume and Patient-Mix at an Emergency Department. Lam CN, Axeen S, Terp S, Burner E, Dworkis DA, Arora S, Menchine M. West J Emerg Med. 2021 Feb 8;22(2):234-243. doi: 10.5811/westjem.2020.12.49234. PMID: 33856306 |
| Geographically Indexed Referral Databases to Address Social Needs in the Emergency Department. Curt A, Khidir H, Ciccolo G, Camargo CA Jr, Samuels-Kalow M. West J Emerg Med. 2021 Mar 4;22(2):218-224. doi: 10.5811/westjem.2020.11.49250. PMID: 33856303 |
| Development, deployment and in-field demonstration of mobile coronavirus SARS-CoV-2 Nucleic acid amplification test. Paton TF, Marr I, O’Keefe Z, Inglis TJJ. J Med Microbiol. 2021 Apr;70(4). doi: 10.1099/jmm.0.001346. PMID: 33856292 |
| Coronavirus-19-Associated Retinopathy. Conrady CD, Faia LJ, Gregg KS, Rao RC. Ocul Immunol Inflamm. 2021 Apr 15:1-2. doi: 10.1080/09273948.2021.1894456. Online ahead of print. PMID: 33856276 |
| Simultaneous Bilateral Central Retinal Artery Occlusion following COVID-19 Infection. Bapaye MM, Nair AG, Bapaye CM, Bapaye MM, Shukla JJ. Ocul Immunol Inflamm. 2021 Apr 15:1-4. doi: 10.1080/09273948.2021.1891262. Online ahead of print. PMID: 33856275 |
| COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Achiron A, Dolev M, Menascu S, Zohar DN, Dreyer-Alster S, Miron S, Shirbint E, Magalashvili D, Flechter S, Givon U, Guber D, Stern Y, Polliack M, Falb R, Gurevich M. Mult Scler. 2021 Apr 15:13524585211003476. doi: 10.1177/13524585211003476. Online ahead of print. PMID: 33856242 |
| Interpreting SARS-CoV-2 Diagnostic Tests: Common Questions and Answers. Nettleton WD. Am Fam Physician. 2021 Apr 15;103(8):465-472. PMID: 33856162 |
| A clinical variant of coronavirus disease 2019 with diarrhoea as the initial symptom compared with other variants. Maslennikov R, Ivashkin V, Ufimtseva A, Poluektova E. Minerva Gastroenterol (Torino). 2021 Apr 15. doi: 10.23736/S2724-5985.21.02827-0. Online ahead of print. PMID: 33856143 No abstract available. |
| COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study. Vrdoljak E, Balja MP, Marušić Z, Avirović M, Blažičević V, Tomasović Č, Čerina D, Bajić Ž, Miše BP, Lovasić IB, Flam J, Tomić S. Oncologist. 2021 Apr 15. doi: 10.1002/onco.13791. Online ahead of print. PMID: 33856084 |
ETIDIoH 
You must be logged in to post a comment.